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ABSTRACT 
The nutraceutical potential of a specific apple cultivar, “Annurca”, was evaluated 
by both in vitro and in vivo studies. Particularly, the effects of Annurca 
polyphenolic extract on lipid uptake and metabolism were evaluated and compared 
with those obtained from polyphenolic extracts coming from other conventional 
cultivars.  
In vitro experiments performed on HepG2 (human hepatocellular liver carcinoma) 
cells indicated Annurca flesh polyphenolic extract as the most active in reducing 
cholesterol and triglyceride uptake (about, 15 and 20 times than control cells, 
respectively), in inhibiting lipase activity (-55% than control cells), in enhancing 
low-density lipoprotein (LDL) receptor binding activity (+46% than control cells), 
in increasing Apolipoprotein A1 (ApoA1) cell expression (+71.4% above control 
levels) and in protecting from oxidative stress (cell proliferation: +47.5%; cell 
radical levels: -33.3% than control cells). All the amazing in vitro properties of 
Annurca flesh polyphenolic extract were attributed to its high content in 
procyanidins, and good linear correlations between procyanidin content and cellular 
effects were registered.  
In vitro experiments of gastrointestinal digestion showed a good bioaccessibility of 
apple procyanidins during the three digestive steps. After salivary digestion, their 
bioaccessibility was 35% of undigested samples, suggesting a potential good 
absorption through the oral mucosa, and it increased during gastric (+5.1% 
compared to salivary digestion) and intestinal (+16% in respect to gastric digestion) 
phases. However, their bioavailability was very low (6.7% of their native pattern 
and 12.0% of the intestinal digestion), suggesting they would act mainly in the gut. 
The small portion absorbed was strongly bound to plasma proteins (93.4%), 
especially to high-density lipoproteins (HDLs, 58.7%), suggesting a role in 
cholesterol metabolism.  
The results of the first clinical trial showed that Annurca apple was the most 
effective, since it decreased total cholesterol (TC, -8.4%) and low-density 
lipoprotein cholesterol (LDL-C, -14.5%) levels, and raised high-density lipoprotein 
cholesterol levels (HDL-C, +14.0%). 
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The results of the second clinical trial showed that the treatment with AppleMetS
TM 
(AMS) resulted in a significant decrease in plasma LDL-C levels (-37.5%), an 
effect comparable to that obtained after treatment with 40 mg of simvastatin or 10 
mg of atorvastatin. Moreover, it increased HDL-C levels of about 49.2%, an effect 
never observed in any pharmaceutical or nutraceutical substance. These amazing 
results suggested that Annurca polyphenols represent an important tool for the 
treatment of mild hypercholesterolemia, especially in elderly people with higher 
values of baseline total cholesterol. 
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RESEARCH OBJECTIVES 
The evidence that the regular consumption of apples leads to beneficial health 
effects, especially to a reduction of CVD (cardiovascular disease) risk, encouraged 
to deepen the nutraceutical potential of the polyphenolic fraction of a specific apple 
cultivar, “Annurca”, by both in vitro and in vivo studies, and to compare its effects 
on lipid uptake and metabolism with those obtained from polyphenolic extracts of 
other conventional cultivars. In fact, dyslipidemia is a pathological imbalance of 
circulating lipoproteins, such as LDLs (low-density lipoproteins), VLDLs (very 
low-density lipoproteins) and HDLs (high-density lipoproteins) and it is considered 
as a major risk factor for the development of cardiovascular diseases (Rosenson et 
al., 2013).  
The research project was structured as follows: 
 qualitative and quantitative profiling of phenolic compounds contained in 
the various apple cultivars by HPLC-DAD/ESI-MS analysis; 
 determination of the effects on metabolic parameters (glucose and lipid 
uptake, cell physiological oxidative stress and hepatic lipid metabolism) by 
experiments performed on HepG2 (human hepatocellular liver carcinoma) 
cells; 
 in vitro definition of some pharmacokinetic parameters (bioaccessibility, 
bioavailability and plasma protein interaction); 
 determination of plasma lipid profile after the regular consumption of 
different apple cultivars (functional foods) or of a nutraceutical consisting of 
Annurca polyphenols (AppleMetS
TM
) by healthy subjects afflicted by mild 
hypercholesterolemia. 
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INTRODUCTION 
The word “nutraceutical” was coined in 1989 by Stephen DeFelice, founder and 
chairman of the Foundation of Innovation in Medicine (FIM), and it derived from 
the crasis of the terms “nutrition” and “pharmaceutical”. A nutraceutical can be 
defined as “a food or a part of a food that provides medical or health benefits, 
including the prevention and/or the treatment of a disease” (Kalra, 2003). 
Functional foods are food and food derivatives that provide beneficial health effects 
in addition to their basic nutritional properties (Menrad, 2003). Functional foods are 
often enriched or fortified with bioactive substances through a process called 
nutrification. Some important examples of functional foods are represented by 
enriched cereals, breads, sport drinks, fortified snack foods, baby foods, prepared 
meals and more. The specific bioactive compounds deriving from foods are known 
as dietary supplements or nutraceuticals and they can be taken in the form of pills, 
powders or other medicinal liquid forms (Wildman, 2001). 
It is well known that some ancient civilizations, such as Indians, Egyptians, 
Chinese and Sumerians, used food as medicine. Hippocrates said, “Let food be thy 
medicine, and medicine be thy food”, suggesting that the ancients were well aware 
of the importance of food for health. The concept of food as medicine is found also 
in folk sayings, such as “An apple a day keeps the doctor away” or “Good wine 
makes good blood”, which suggest that a certain type of food or beverage could 
prevent some kinds of disease.  
Currently, there are many data that allow stating the importance of the combination 
between good nutrition and good health. For example, epidemiological and clinical 
trials have demonstrated that a nutrition rich in fish is associated with a minor risk 
of emergence of cardiovascular diseases, due to the effects of omega-3 fatty acids, 
such as EPA (eicosapentaenoic acid, C20:5n-3) and DHA (docosahexaenoic acid, 
C22:6n-3) (Kris-Etherton et al., 2002). Other epidemiological trials have reported 
the existence of anticancer properties in green tea, due to its content in phenolic 
compounds, such as (-)-epigallocatechin gallate (EGCG) (Jankun et al., 1997). 
Thus, this is the context of my Ph.D. research project in Pharmaceutical Science.  
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My research activity has been focused on the evaluation of the nutraceutical 
potential of vegetal food products typical of Campania region, an area situated in 
the southern part of the Italian peninsula. The ancient Romans named it “Campania 
Felix” because of its prosperity, which is due to the conspicuous presence of 
volcanic soils that ensure high land fertility and are responsible for a particularly 
developed agricultural sector. Many typical products of this region are considered 
as products of excellence and have qualitative characteristics that depend 
essentially or exclusively on the territory where they grow. Some of these products 
obtained recognitions by European Union, such as PGI (Protected Geographical 
Indication) and PDO (Protected Designation of Origin).  
Particularly, my attention has been addressed to a typical apple cultivar (Malus 
pumila Miller) named “Annurca”, which is listed as a PGI product and is known as 
“Mela Annurca Campana IGP”. The choice of studying this fruit arose from the 
evidence that the regular consumption of apples is associated with beneficial effects 
on health. It has been reported that the regular consumption of apples results in a 
reduction of cardiovascular risk (Knekt et al., 1996) and cerebrovascular diseases 
(Knekt et al., 2000). The protective effect of apples against the occurrence of 
cardiovascular events could be due to their potential cholesterol-lowering ability. 
Aprikian et al. reported that rats fed with cholesterol and lyophilised apples show 
lower levels of plasma and liver cholesterol, higher concentration of high-density 
lipoproteins and increased cholesterol excretion in the feces (Aprikian et al., 2001). 
Apple consumption is also associated with a reduced risk of developing type II 
diabetes (Knekt et al., 2002). Moreover, eating apples on a regular basis may 
reduce the emergence of certain types of cancer, such as liver, colon, lung and 
prostate cancers (Riboli et al., 2003).  
The magic ingredients contained in apples and considered as the responsible for 
their healthful properties are polyphenols, which include mainly flavonoid 
derivatives, such as flavonols, flavanols, anthocyanins, dihydrochalcones and 
phenolic acids (Alonso-Salces et al., 2004). 
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CHAPTER 1 
Mela Annurca Campana IGP 
1.1 Origin and history 
“Mela Annurca Campana IGP” is a precious apple cultivar (Malus pumila Miller), 
typical of Campania region. It is present in this geographical area for at least two 
millennia, since some depictions of this fruit were found in some paintings in the 
ruins of Herculaneum. Specifically, its place of origin would be the area near 
Pozzuoli, as it can be deduced from the “Naturalis Historia” by Pliny the Elder. He 
named it “Mala Orcula” because of the proximity of Pozzuoli to Averno Lake, 
which, according to the ancients, was the location of the underworld, so it was 
produced near the Orcus. From “Mala Orcula” the names “anorcola” and 
“annorcola” were derived and they were used until 1876, when the name 
“Annurca” appeared for the first time in the “Manuale di Arboricoltura” written by 
the botanist Giuseppe Antonio Pasquale. In the past, this cultivar was traditionally 
grown in Phlegraean and Vesuvian areas, often in small companies and along with 
vegetables and other fruits, but, because of the regression of the agricultural areas 
in Naples, it is currently cultivated in other areas of Campania region, especially in 
the areas of Caserta and Benevento. 
 
1.2 Product description  
“Mela Annurca Campana IGP” is considered as the queen of apples (Figure 1) and 
it has specific characteristics, described in its disciplinary of production. 
 
Figure 1: Mela Annurca Campana IGP. 
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The fruit is medium to small and slightly asymmetrical. The minimum dimensions 
required are 60 mm in diameter and 100 g in weight. The shape is flattened and 
roundish and there is a short and weak stalk. When the fruit is harvested, the peel 
appears yellowish-green, with red stripes on 50-80% of the surface, but they can 
reach 90-100% of the surface after the reddening on the ground. The rind is smooth, 
waxy, moderately rusty, especially in the stem cavity, and has numerous small 
lenticels. The flesh is white, juicy, firm and crispy and has a very high acid/sugar 
ratio, which is responsible for a pleasantly acidulous and fragrant flavour.  
Two different ecotypes are possible: “Annurca” and “Annurca Rossa del Sud”, 
which is a natural mutant and is characterised by fruits with red skin before the 
reddening on the ground. 
 
1.3 Production 
The disciplinary of production of Mela Annurca Campana IGP indicates that its 
production is possible only in 137 municipalities of Campania region. 
The cultivation takes place in apple orchards, where it is possible to find other 
apple cultivars up to a maximum of 10% of the plants. Several cultivation methods 
are allowed; the number of plants per hectare is variable, but it cannot be greater 
than 1200 plants/Ha. 
The harvesting takes place in mid-September and it is made by hand. After the 
collection, apples are subjected to the reddening on the ground in the so-called 
“melai”, which are small plots of land, not larger than 1.50 meters. “Melai” are 
covered by soft material layers, such as hemp, pine needles, wood shavings or other 
plant materials and they are arranged in order to avoid water stagnation and to be 
protected from the sun. During their permanence there, apple fruits are arranged in 
rows; they are sprayed daily with water and cannot receive any plant health 
treatment. When a part of the surface of the fruit becomes red, the apples are turned 
to allow the reddening on the opposite side (Figure 2). 
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Figure 2: A typical “melaio”. 
Finally, apples are accurately inspected in order to discard fruits that appear 
damaged or rotten. Moreover, fruits must not have parasites or pesticide residues. 
This peculiar treatment lasts for about one month and allows the final product to 
reach its typical taste and quality characteristics (Insero, 2004). The harvesting and 
reddening operations have to be concluded by December, 15
th
.   
 
1.4 PGI Recognition  
PGI is the acronym of Protected Geographical Indication. According to the 
Regulation (EC) No. 510/2006, “it is the name of an area, a specific place or, in 
exceptional cases, the name of a country, used as a description of an agricultural 
product or a foodstuff, 
 which comes from such an area, place or country; 
 which has a specific quality, goodwill or other characteristic property, 
attributable to its geographical origin; 
 at least one of the stages of production, processing or preparation takes 
place in the area.” 
Thus, in order to receive the PGI recognition, the entire product must be 
traditionally and at least partially manufactured (prepared, processed or produced) 
within the specific region and consequentially acquire unique properties. 
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Annurca apple cultivar received PGI recognition from the European Council 
[Commission Regulation (EC) No. 417/2006] according to the conditions and 
requirements established by Regulation (EC) No. 2081/1992 (Figure 3). 
 
Figure 3: “Mela Annurca Campana IGP” logo. 
The Italian Ministry of Agriculture, Food and Forestry Policies authorised 
Is.Me.Cert (Istituto Mediterraneo per la Certificazione dei prodotti e dei processi 
nel settore agroalimentare) to perform conformity checks in order to give the 
authorization to use the registered name “Mela Annurca Campana IGP” (Decree of 
26 February 2003). Checks are performed both in the office and in the companies 
and include document controls, inspections and analytical test on batches. The aim 
of these controls is to verify the compliance to the established requirements, such as 
origin, conformity of cultivation methods and of product, traceability of products, 
respect of labeling rules and so on. Moreover, the Italian Ministry of Agriculture, 
Food and Forestry Policies recognised the existence of “Consorzio di tutela Mela 
Annurca Campana IGP”, that aims to protect, to monitor and to promote the 
product (Decree of 18 April 2007).  
 
1.5 Economical and production data 
The annual production of Annurca apple cultivar is about 60000 tonnes and it 
represents 60% of apple production of Campania region and 5% of Italian apple 
production (D‟Abrosca et al., 2006). Currently, about 2/3 of the harvest are sold in 
Campania and Lazio regions, while the remaining 20% arrive in Liguria, 
Lombardia, Piemonte and Toscana regions.  
Data published in 2005 reported that the surface enrolled in the PGI certification 
system is 288 hectares and the farms entered in the register are 86, so the total 
certified production is about 25000 tonnes. 
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1.6 Nutritional and health value 
Table 1 shows the nutrient composition of Annurca apple, according to the data 
reported in the database of C.R.E.A. (Centro di Ricerca per gli Alimenti e la 
Nutrizione). Although the quantity of micronutrients is not shown in this table, 
several types of vitamins (such as thiamine, riboflavin, niacin and ascorbic acid), 
and different kinds of minerals (such as potassium, iron, phosphorus and 
manganese) are contained.  
Table 1: Nutrient composition of Annurca apple. 
Nutrient component Quantity in 100 g 
Water (g) 84.3 
Proteins (g) 0.3 
Lipids (g) 0.1 
Cholesterol (g) 0 
Available carbohydrates (g) 10.2 
Soluble sugars (g) 10.2 
Total fiber (g) 2.2 
Energy (kcal) 
Energy (kJ) 
40 
169 
 
In addition to the above-mentioned nutritional properties, Annurca apple has shown 
several beneficial health effects. As reported in the introduction, all apple cultivars 
are rich in secondary metabolites, whose positive effects on health have already 
been reported in previous studies. Thus, several authors have studied Annurca apple 
cultivar in order to analyse its contribution to health. 
Annurca secondary metabolites have been reported to have an important 
antioxidant activity. Cefarelli et al. reported that they have inhibiting activity 
against the autoxidation of methyl linoleate, peroxide scavenging activity and 
DPPH scavenging activity (Cefarelli et al., 2006). The strong antioxidant 
compounds contained in Annurca apple are able to prevent endogenous damage 
both in vitro (human gastric epithelial cells) and in vivo (rat gastric mucosa). 
Particularly, Annurca polyphenolic extract may counteract the damaging effect 
deriving from ROS (Reactive Oxygen Species) and such a protective effect is 
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mainly attributable to its major components, catechin and chlorogenic acid 
(Graziani et al., 2005).  
Another work reported that Annurca polyphenolic extract, which is rich in 
chlorogenic acid, catechin and epicatechin, has potent demethylating activity due to 
the capacity of inhibiting DNA methyltransferase and of regulating apoptosis and 
cell viability; as a result, it could be considered an excellent chemopreventive of 
colorectal cancer, since it is known that hypermethylation of the promoter of 
hMLH1 and subsequent microsatellite instability occurs in 12% of sporadic 
colorectal cancers (Fini et al., 2007).  
Mari et al. compared three different apple cultivars and reported that Annurca 
polyphenolic extract is richer than those obtained from Red Delicious and Golden 
Delicious cultivars. Furthermore, it was the most effective in decreasing cell 
viability and in increasing the activity of the enzyme caspase-3, which has a key 
role in apoptosis cascade. Both the cytotoxic and the apoptotic effects depend on 
the qualitative composition of polyphenols and not only on the total content (Mari 
et al., 2010).  
Annurca polyphenolic extract has also shown a good antimicrobial activity, since it 
determines inhibition halos against some pathogen bacteria such as Bacillus cereus 
and Escherichia coli. Moreover, the same work reported that Annurca polyphenolic 
extract does not induce any evident gene mutations, suggesting that it also exhibits 
antimutagenic properties (Fratianni et al., 2007).  
To sum up, all the papers reported herein agree on the recognition of polyphenols 
as the compounds responsible for these important and positive effects both in vitro 
and in vivo. 
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CHAPTER 2 
Polyphenols 
Polyphenols represent a large and heterogeneous family of secondary metabolites, 
widely spread in plant kingdom and commonly found both in edible and non edible 
plants (El Gharras, 2009). These compounds are chemicals produced by plants in 
order to confer some properties, such as resistance against ultraviolet radiations and 
aggressions by pathogens (Beckman, 2000). Moreover, polyphenols are considered 
as the responsible for some characteristics of foods and beverages deriving from 
plants, since they contribute to the taste, colour and nutritional properties 
(Cheynier, 2005).  
The main sources of polyphenols are fruit and beverages, such as red wine, coffee 
and tea; other important sources are vegetables, cereals and leguminous plants (El 
Gharras, 2009). Some of these compounds are ubiquitous (e.g. quercetin is present 
in all plant products); others are specific to particular plants (e.g. isoflavones are 
found only in soy products; flavanones are typical of citrus fruit and phloridzin is 
contained only in apples). In general, foods contain complex mixtures of 
polyphenols, but, unfortunately, they are too often scarcely characterised (Manach 
et al., 2004).  
 
2.1 Classification  
Polyphenolic compounds are divided in different classes according to their number 
of phenolic rings and the structural elements that allow the binding between the 
rings (El Gharras, 2009). Nevertheless, they are usually distinguished in flavonoids 
and nonflavonoids (Cheynier, 2005).  
 
2.1.1 Flavonoid compounds 
Among polyphenolic compounds, flavonoids represent the largest group: more than 
4000 molecules have been identified and the list is constantly growing (Harborne et 
al., 2000). Such a complexity is due to the occurrence of numerous substitution 
patterns in which primary substituents can be replaced by other chemical groups; 
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for example, the molecules can be glycosylated or acylated, forming highly 
complex structures. 
Flavonoids have a skeleton of diphenylpropanes. They consist of two phenolic 
rings, named A and B, that are linked together by three carbon atoms, forming an 
oxygenated heterocyclic ring, named C. According to the oxidation state of the 
heterocyclic ring, flavonoids are divided in six different subclasses (Figure 4) 
(Manach et al., 2004):  
 flavonols; 
 flavones; 
 flavanones; 
 isoflavones; 
 anthocyanidins; 
 flavanols (or flavan-3-ols). 
 
Figure 4: Different subclasses of flavonoids. 
The most ubiquitous flavonoids in foods are flavonols, which are generally present 
at relatively low concentrations (about 15-30 mg/kg FW). Flavonols present a 
 
 
 
14 
 
double bond between C2 and C3, an oxygen atom at the C4 position and a hydroxyl 
group at the C3 position (de la Rosa et al., 2010). The main representatives of this 
class are quercetin and kaempferol. Generally, these molecules are in glycosylated 
forms and the sugar portion is represented by glucose, rhamnose, galactose, 
arabinose, xylose and glucuronic acid. The richest foods and beverages are onions, 
curly kale, leeks, broccoli, blueberries, red wine and tea (Manach et al., 2004). 
Flavones have a double bond between C2 and C3 and a ketone group at the C4 
position (de la Rosa et al., 2010). They are much less spread in fruit and vegetables 
than flavonols, and they are found principally in parsley and celery. This class 
includes mainly glycosides of luteolin and apigenin (Manach et al., 2004). 
Flavanones are also named dihydroflavones. In these molecules, the ring C is 
saturated and presents an oxygen atom at the C4 position (de la Rosa et al., 2010). 
The main sources in human foods are tomatoes and some aromatic plants, such as 
mint, but the richest are citrus fruits. These compounds appear generally 
glycosylated by a disaccharide at position 7: the main aglycones are naringenin 
(present in grapefruit), hesperetin (found in orange) and eriodictyol (found in 
lemon) (Manach et al., 2004). 
Isoflavones have B and C rings linked through C3 position, instead of C2 position, 
peculiar of the other kinds of flavonoids (de la Rosa et al., 2010). They are found 
almost exclusively in leguminous plants, both as glycosides and aglycones. The 
most important sources in human diet are represented by soy and soybean-derived 
products. Genistein, daidzein and glycitein are the most important compounds that 
belong to this class (Manach et al., 2004).  
The ring C of flavanols (or flavan-3-ols) is saturated and has a hydroxyl group at 
the C3 position (de la Rosa et al., 2010). These molecules can be found both in 
monomeric and in polymeric forms. Among monomers, the most important are 
catechins, such as (+)-catechin, (-)-epicatechin, (-)-epigallocatechin, (+)-
gallocatechin and their gallate derivatives; among polymers, the main 
representatives are proanthocyanidins, named also condensed tannins, constituted 
by 4-11 units. The monomers catechin and epicatechin are the main flavanols 
contained in fruit, while gallocatechin, epigallocatechin and epigallocatechin gallate 
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are present mainly in teas. The polymers proanthocyanidins are found mainly in 
grapes (Manach et al., 2004).  
The last class of flavonoids is represented by anthocyanidins, which exist mainly in 
the glycosylated and esterified forms (anthocyanins), because of the high instability 
of the aglycone form (Manach et al., 2004). Anthocyanins are based on the 
flavylium salt structure (de la Rosa et al., 2010); the glycosylation occurs mainly 
with glucose, galactose, rhamnose, xylose, arabinose, and fructose, whereas the 
esterification occurs with various organic acids (such as citric acid or malic acid) 
and phenolic acids. Fruit, red wine, some varieties of cereals and some kinds of 
vegetables (aubergines, cabbage, beans, onions and radishes) are the richest foods 
and beverages in human diet. The most common anthocyanidin in food is 
represented by cyanidin (Manach et al., 2004). 
 
2.1.2 Nonflavonoid compounds 
Nonflavonoid compounds are characterised by heterogeneous chemical structures 
and are classified into three groups: phenolic acids, lignans and stilbenes (Cheynier, 
2005).  
Phenolic acids are distinguished in derivatives of benzoic acid and derivatives of 
cinnamic acid. Hydroxybenzoic acids are found in small quantities only in a few 
plants used by humans, both in free and in esterified forms: the most important are 
protocatechuic acid and gallic acid. Hydroxybenzoic acids are the components of 
more complex structures, such as gallotannins and ellagitannins. Hydroxycinnamic 
acids are more common than hydroxybenzoic acids and consist mainly of p-
coumaric acid, caffeic acid, ferulic acid and sinapic acid. These compounds are 
found in the form of glycosylated derivatives and esters of quinic acid, shikimic 
acid and tartaric acid (Figure 5) (Manach et al., 2004).  
 
Figure 5: Phenolic acids. 
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Lignans are diphenolic compounds containing a 2,3-dibenzylbutane structure. They 
can be found in traces in cereals, grains, fruit and some vegetables, but the richest 
source is linseed, which contains chiefly secoisolariciresinol and small quantities of 
matairesinol (Manach et al., 2004) (Figure 6). 
 
Figure 6: Lignans. 
Finally, stilbenes are hydrocarbons consisting of ethene substituted with a phenyl 
group on both carbon atoms involved in the double bond. The most important 
exponent is resveratrol, which is contained chiefly in red wine (Manach et al., 
2004) (Figure 7). 
 
Figure 7: Stilbenes. 
 
2.2 Biosynthesis 
The biosynthesis of these molecules is the result of several chemical reactions 
catalysed by various enzymes, which are regulated by both exogenous (such as 
light, temperature, water availability and pathogens) and endogenous (such as 
hormones) factors. In higher plants, the majority of phenolic compounds derive 
from the amino acid phenylalanine, a product of the shikimic acid pathway, which 
converts products deriving from the metabolism of carbohydrates, such as 
phosphoenolpyruvate and erythrose-4-phosphate, in essential aromatic amino acids, 
such as phenylalanine, tyrosine and tryptophan.  
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The biosynthesis of flavonoids needs as initial substrates one molecule of p-
coumaroyl-CoA and three molecules of malonyl-CoA. P-coumaroyl-CoA is formed 
through a synthetic pathway, involving three steps and enzymes. Firstly, the amino 
acid phenylalanine is deaminated and transformed in trans-cinnamic acid through 
an important enzyme, named phenylalanine ammonia lyase (PAL). Subsequently, 
trans-cinnamic acid is converted in p-coumaric acid thanks to the action of the 
enzyme cinnamate 4-hydroxylase (CA4H). Finally, the action of the enzyme 4-
coumaroyl-CoA ligase (4CL) turns p-coumaric acid in the corresponding CoA 
thioester. Malonyl-CoA is formed in the reaction catalysed by the enzyme acetyl-
CoA carboxylase (ACC) (Vogt, 2010).  
Thus, three molecules of malonyl-CoA and one molecule of p-coumaroyl-CoA are 
substrates for the enzyme chalcone synthase (CHS), which catalyses a series of 
sequential decarbossilations and condensations, leading to the formation of 
naringenin chalcone. Naringenin chalcone is turned into the flavanone naringenin, 
by the action of chalcone isomerase (CHI). Naringenin represents the progenitor of 
all successive flavonoid structures (de la Rosa et al., 2010).  
Malonyl-CoA and p-coumaroyl-CoA are also the substrates of stilbene synthase 
(STS), which is an important enzyme for the formation of stilbene skeleton (de la 
Rosa et al., 2010). 
As regards phenolic acids and lignans, they have a common precursor that is 
represented by p-coumaric acid (de la Rosa et al., 2010). 
 
2.3 Biological properties 
As reported above, phenolic compounds are secondary metabolites that are useful 
for the plants which produce them. Firstly, these molecules can give a certain 
resistance against some agents, such as ultraviolet rays and pathogens (Beckman, 
2000). Since they are coloured pigments, these compounds are the responsible for 
the colour of flowers and fruits in which they are contained: flavonols and flavones 
are yellow (Cheynier, 2005), while anthocyanins exhibit pink, red, purple or blue 
colours according to the chemical structure and the pH (Manach et al., 2004). 
Polyphenols are also considered as the responsible for the taste of foods and 
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beverages in which they are contained, and they give an astringent and bitter taste 
(Cheynier, 2005). 
During the last decades, a continuous and growing interest for polyphenols has 
been occurred and numerous studies have been devoted to these molecules, their 
occurrence in plants and food coming from plants, and their effects on food quality. 
Furthermore, a lot of epidemiological studies and associated meta-analysis have 
reported that polyphenols or polyphenol-rich diet may play a significant role in 
health, since they can protect against the development and progression of some 
pathologies that are associated with oxidative stress, such as cancer, cardiovascular 
and neurodegenerative diseases, diabetes and osteoporosis (Graf et al., 2005; Arts et 
al., 2005). Polyphenols, in fact, are strong antioxidant and they can act both as 
chain breakers and as radical scavengers (Rice-Evans, 2001), thanks to the fact that 
the phenolic groups can accept an electron and form stable phenoxyl radicals. Thus, 
by virtue of their antioxidant properties, they may protect cell constituents from 
oxidative damage and reduce the risk of onset of various degenerative diseases 
associated with oxidative stress (Pandey et al., 2009). 
Polyphenols may reduce the number of tumors and their growth. Such an effect has 
been observed for various types of cancer, such as mouth, stomach, duodenum, 
colon, liver, lung, mammary gland and skin tumors. The chemopreventive effects 
of polyphenols are due to several mechanisms of action, such as antioxidant and 
anti-inflammatory activities, inhibition of proliferation, induction of cell cycle 
arrest, induction of apoptosis, induction of cytochrome P450 enzymes and changes 
in cellular signalling (Yang et al., 2001; García-Lafuente et al., 2009). 
As regards the cardio-protective effects, polyphenols are considered as potent 
inhibitors of LDL oxidation, which is associated with the development of 
atherosclerosis and the resulting coronary heart diseases and myocardial infarctions 
(Aviram et al., 2000).  In addition, polyphenols may exert protective effects against 
cardiovascular diseases by performing antioxidant, antiplatelet and anti-
inflammatory actions, by increasing HDL levels and by improving endothelial 
functions (García-Lafuente et al., 2009).  
Polyphenols have also shown neuroprotective action. Since they have antioxidant 
activity, they may protect against the development of pathologies characterised by 
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oxidative damage, such as Alzheimer's and Parkinson‟s diseases (Dai et al., 2006; 
Aquilano et al., 2008). 
Finally, polyphenols have been found to have other several health beneficial effects 
(Pandey et al., 2009). Dietary polyphenols are efficient in the treatment of asthma; 
in fact, epidemiological studies have shown the occurrence of a decreased 
prevalence and incidence of asthma and an enhanced pulmonary function after 
apple intake. Isoflavones are considered beneficial for the treatment of 
osteoporosis. Different kinds of polyphenols have shown antidiabetic effects, 
through different mechanisms that include the inhibition of glucose absorption into 
the intestine or of glucose uptake by peripheral tissues. 
Specifically, flavonoids have been reported as the main responsible for antioxidant, 
anticarcinogenic and antiatherosclerotic actions (Wang et al., 2000). 
 
2.4 Bioaccessibility and bioavailability 
Although polyphenols are widely distributed in the plant kingdom, their total 
content in plant products is often difficult to estimate, because of the occurrence of 
several factors, such as ripeness at the time of harvest, environmental factors (e.g. 
sun exposure, rainfall, type of culture, fruit yield per tree), storage and methods of 
culinary preparation (e.g. cooking and peeling) (D‟Archivio et al., 2007). 
Moreover, there are not unequivocal data about the daily intake of polyphenols, 
because it depends chiefly on dietary habits and preferences of the individuals and 
may vary considerably in relation to the type, quality and quantity of the plant 
product consumed. For example, heavy coffee drinkers will likely consume more 
phenolic acids than flavonoids, whereas people that consume fruits or beverages 
such as red wine, tea, chocolate or beer, will likely take flavanols, such as 
catechins, proanthocyanidins, anthocyanins and their oxidation products (Scalbert 
et al., 2000). 
In order to obtain any effect in specific tissues or organs, polyphenols must be 
available and their bioavailability is influenced by several processes that occur in 
the LADME (Liberation, Absorption, Distribution, Metabolism and Excretion) 
scheme. Therefore, the step of liberation of the bioactive compounds from the food 
matrix in the gastrointestinal tract is of fundamental importance to ensure that they 
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enter into the systemic circulation and become bioavailable. As regards the 
intestinal absorption, aglycones can be directly absorbed from the small intestine, 
whereas glycosides have to be hydrolysed by the intestinal enzymes or by the 
colonic microflora. Later, polyphenols undergo both in the intestine and in the liver 
to highly efficient metabolic conjugation processes (such as methylation, sulfation 
and glucuronidation) that aim to detoxify these xenobiotics, increasing their 
hydrophilicity and promoting their excretion through bile and urine: thus, 
circulating polyphenols are conjugated derivatives, strongly bound to plasmatic 
proteins, especially albumin (Manach et al., 2004; Pandey et al., 2009). 
Considering the above, despite the consumption of polyphenols is usual, not 
necessarily these compounds are able to exert biological activity within the 
organism. In fact, polyphenol bioavailability is not the same for the various 
molecules and there is no relationship between their concentration in food and their 
bioavailability in human body because only their chemical structure is responsible 
for the absorbed quantity and for the type of circulating metabolites (Pandey et al., 
2009).  
Ingested phenolic compounds could have a lower intrinsic activity or be scarcely 
absorbed from the intestine, highly metabolised or quickly eliminated (Manach et 
al., 2004). In fact, gastrointestinal digestion conditions may lead to drastic 
structural changes that could alter the stability, bioavailability and bioactivity of 
food constituents. Cilla et al. reported that the digestion process may lead to a 
reduction in phenolic content by at least 47% in digested fruit beverages compared 
to those not subjected to digestion (Cilla et al., 2009). Another work reported that 
only 62% of originally present polyphenols in grapes are bioaccessible after gastro-
intestinal digestion (Tagliazucchi et al., 2010).  
The evidence of the absorption of polyphenols through the gut is given by both 
direct and indirect methods. Direct methods consider the measuring of the 
concentration of phenolic compounds in plasma and urine after the ingestion of 
polyphenol-rich foods (Young et al., 1999; Tian et al., 2006). Indirect methods 
consider the increase in plasma antioxidant capacity after the consumption of 
polyphenol-rich foods (Duthie et al., 1998; Young et al., 1999).  
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Finally, it is important to understand that there is a great inter-individual variability 
in producing metabolites and that they may have lost or preserved their biological 
activity, so their identification and quantification represent an important field of 
research (D‟Archivio et al., 2007). 
 
2.5 Polyphenols contained in apples 
As mentioned above, foods and beverages contain complex mixtures of 
polyphenols, but unfortunately they are too often poorly characterised. However, 
certain studies have focused on the characterisation of the phenolic fraction that is 
contained in apples. Therefore, data on the polyphenolic profile of apples exist, but 
as regards the quantity of polyphenols, there are no univocal data because it 
depends on a lot of factors. In addition, the quantitative profile is different when 
considering the flesh or the peels. In general, these compounds are more abundant 
in the peel than in the flesh, maybe because the skin is subjected to injuries more 
than the pulp, so it needs more protection from pathogen attacks (Escarpa et al., 
1998; Lamperi et al., 2008). Since apple peels contain more polyphenols than apple 
pulp, the antioxidant activity and the bioactivity for the peel may be higher than for 
the flesh (Boyer et al., 2004).  
The polyphenolic compounds present in apples belong to different classes: 
flavanols, flavonols, anthocyanins, hydroxycinnamic acids and dihydrochalcones 
(Alonso-Salces et al., 2004; Vrhovsek et al., 2004).  
Flavan-3-ols are the most abundant polyphenols contained in apples. In fact, they 
constitute between 71% and 90% of total phenolic amount and consist mainly of    
(-)-epicatechin and (+)-catechin, present in the form of both monomers (Figure 8) 
and oligomers, named procyanidins (Figure 9). 
 
Figure 8: (+)-catechin (on the left) and (-)-epicatechin (on the right). 
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Figure 9: Basis structure of procyanidins. 
Flavonols are the strongest antioxidant compounds. They range from 1% to 11% of 
total phenolic amount and are represented chiefly by quercetin (Figure 10) and 
some of its glycosides, such as hyperin (quercetin-3-O-galactoside), isoquercitrin 
(quercetin-3-O-glucoside), rutin (quercetin-3-O-rutinoside), avicularin (quercetin-3-
O-α-arabinofuranoside) and quercitrin (quercetin-3-O-rhamnoside).  
 
Figure 10: Quercetin. 
The main anthocyanin present in apples is a glycoside of cyanidin, also named 
ideain (cyanidin-3-O-galactoside) (Figure 11). Its concentration goes from 1% to 
3% of total phenolic content in red apples.  
 
Figure 11: Cyanidin-3-O-galactoside or ideain. 
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Apples also contain hydroxycinnamic acids in a percentage ranging from 4% to 
18% of apple polyphenols: the most representative is chlorogenic acid (Figure 12), 
followed by 4-p-coumaroylquinic acid.  
 
Figure 12: Chlorogenic acid. 
Finally, apples contain dihydrochalcones, that are bicyclic flavonoids, ranging from 
2% to 6% of total polyphenols: the most important are phloretin (Figure 13) and its 
glycosides, phloretin-2‟-O-glucoside (also known as phloridzin) and phloretin-2‟-
O-xyloglucoside.  
 
Figure 13: Phloretin. 
The above-mentioned differences in concentration ranges are due to the fact that 
there are large varietal differences and, in the context of a same apple variety, there 
may be differences due to environmental factors, such as sun exposure, use of 
certain fertilization methods and stage of fruit development. Apple storage in 
controlled conditions does not affect the concentration of phytochemicals, whereas 
processing results in a very significant decrease in phenolic compounds and 
antioxidant activity (Boyer et al., 2004).  
In relation to post-harvest operations, it is very important not to forget that the 
apple cultivar considered in this thesis work is subjected to a peculiar treatment on 
the basis of its disciplinary of production. Does the reddening on the ground 
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treatment affect the phenolic composition of Annurca apple? According to a paper 
previously published, the concentration of phenolic compounds tends to increase 
during the reddening-ripening process in the peels, but not in the flesh. This effect 
could be due to the ethylene action, a hormone able to stimulate the activity of 
phenylalanine ammonia lyase (PAL), which is the most important enzyme in 
polyphenol biosynthetic pathway. Consequently, the antioxidant activity of peels 
increases during the reddening process, so polyphenols coming from Annurca are 
considered relatively stable and maintain health benefits also after storage 
(D‟Angelo et al., 2007). 
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CHAPTER 3 
Characterisation of apple polyphenolic extracts and in vitro metabolic 
effects  
3.1 Materials and methods 
3.1.1 Reagents and standards 
All chemicals and reagents used were either analytical-reagent or HPLC grade. The 
water was treated in a Milli-Q water purification system (Millipore, Bedford, MA) 
before use. The standards used for the identification and quantification of phenolic 
acids and flavonoids were: chlorogenic acid, (+)-catechin, (-)-epicatechin, 
isorhamnetin, myricetin, phloretin, phloridzin (phloretin-2-O-glucoside), 
procyanidin B2, quercetin, quercitrin (quercetin-3-O-rhamnoside), rutin (quercetin-
3-O-rutinoside), isoquercitrin (quercetin-3-O-glucoside), hyperin (quercetin-3-O-
galactoside) and cyanidin-3-O-galactoside chloride (Sigma Chemical Co., St. 
Louis, MO). Acetonitrile and methanol were of HPLC grade (Carlo Erba, Milano, 
Italy). 
 
3.1.2 Fruit collection and sample preparation 
Annurca (Malus pumila Miller cv Annurca) apple fruits were collected in Valle di 
Maddaloni (Caserta, Italy) in October when fruits had just been harvested (green 
peel). Fruits were reddened, following the typical treatment (Lo Scalzo et al., 2001) 
for about 30 days, and then analysed. Other four apple varieties analysed in this 
study, Red Delicious (RD) (Malus pumila Miller cv Red Delicious), Pink Lady 
(PL) (Malus pumila Miller cv Pink Lady), Fuji (F) (Malus pumila Miller cv Fuji) 
and Golden Delicious (GD) (Malus pumila Miller cv Golden Delicious), were 
purchased in a local supermarket. Lyophilised apple peels and flesh (10 g) were 
treated with 100 mL of a methanol/water mixture (80:20, v/v) acidified with 0.5% 
formic acid for 24 h at 4 °C in order to extract phenolic compounds. After 
centrifugation, the supernatant was slowly filtered and purified through an 
Amberlite XAD-2 column packed as follows: 10 g of resin (pore size 9 nm; particle 
size 0.3-1.2 mm; Supelco, Bellefonte, PA) was soaked in methanol, stirred for 10 
min and then packed into a glass column (10 x 2 cm). The column was washed with 
 
 
 
26 
 
100 mL of acidified water (pH 2) and 50 mL of deionised water in order to remove 
sugar and other polar compounds. The adsorbed phenolic compounds were 
extracted from the resin by elution with 100 mL of methanol, which was evaporated 
by flushing with nitrogen. The polyphenolic extracts were stored at -80 °C until 
analysis.  
 
3.1.3 HPLC-DAD/ESI-MS
n 
analysis 
HPLC separation and quantification of phenolic compounds in apple peel and flesh 
extracts were performed according to previous studies with some modifications 
(Mari et al., 2010). The identification of phenolic compounds was possible by 
recording chromatograms at different wavelengths, 280 nm for flavonols, 
procyanidins, dihydrochalcones and hydroxycinnamic acids, and 500 nm for 
anthocyanins and by comparing spectra and retention times with those of 
commercial standards and with those reported in previous works (Mari et al., 2010). 
Elution conditions consisted in 2% acetic acid (solvent A) and 0.5% acetic acid in 
acetonitrile and water (50:50, v/v) (solvent B) gradient at a flow rate of 1.0 
mL/min. The column selected was a Hypersil BDS C18 column (250 mm x 4.6 
mm, 5 µm) (Thermo, Bellefonte, PA). Analyses were run on a Finnigan HPLC 
system (Thermo Electron Corporation, San Jose, CA) provided with photodiode 
array detector (DAD). The gradient conditions were: 0-5 min, 10% B; 55 min, 55% 
B; 65 min, 95% B, followed by 5 min of maintenance. The identity of phenolic 
acids and flavonoids was confirmed with LC-ESI/MS/MS experiments and data 
were compared with those of commercial standards and with those reported in 
previous works (Mari et al., 2010). The same chromatographic conditions were 
applied to a HP1100 HPLC system (Agilent, Palo Alto, CA) coupled to a PE-Sciex 
API-2000 triple-quadrupole mass spectrometer (AB Sciex, Warrington, UK) 
equipped with a Turbospray (TSI) source. Individual phenols were separated on a 
Hypersil BDS C18 column (250 mm x 2.1 mm, 5 µm) (Thermo Electron, 
Bellefonte, PA) at a flow rate of 200 µL/min. Mass spectra were recorded from m/z 
= 50 to 1500, in both negative and positive ionisation mode. For negative ion mode, 
the capillary voltage was set at -13 V, the spray voltage was at 4.5 kV and the tube 
lens offset was at -15 V, while in positive ion mode, the capillary voltage was set at 
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13 V, the spray voltage was at 5 kV and the tube lens offset was at -35 V. The 
capillary temperature was 275 °C. Data were acquired in MS, MS/MS and MS
n 
scanning modes.  
 
3.1.4 Cell culture 
Human hepatocellular liver carcinoma cells (HepG2, HB-8065) were obtained from 
American Type Culture Collection. Monolayers of cells were grown in T75 flasks 
and maintained in DMEM (Dulbecco‟s Modified Eagle‟s Medium) (Sigma 
Chemical Co., St. Louis, MO) supplemented with 10% (v/v) fetal bovine serum 
(FBS), 1% antibiotic/antimycotic solution (Gibco-Invitrogen, Mount Waverley, 
Australia), 0.375% NaHCO3 and 20 mmol/L HEPES, pH 7.4, and incubated at 37 
°C in a humidified atmosphere of 5% CO2 in air. The cells were dispersed with 
trypsin-EDTA (0.05% trypsin and 0.02% EDTA) and plated on the bottom of a 
transparent black 96-well plate in a 200 µL growth medium at a density of 1.0 x 10
5 
cells/mL. Assays were performed by incubating the culture with 1 µg/mL of apple 
polyphenolic extract for 72 h.  
 
3.1.5 Glucose uptake 
Cells were washed twice with 2 mL of HEPES buffer solution A (HEPES, 20 mM; 
NaCl, 137 mM; KCl, 4.7 mM; MgSO4, 1.2 mM; CaCl2, 1.8 mM) in both upper and 
lower compartments (pH 7.4). After washing, 1 mL of HEPES buffer containing D-
[U-
14
C] glucose 0.5 mCi/mL and 1 mM total glucose (solution B) was added to the 
upper compartment. Cells were then incubated for 30 min at 37 °C, the electrical 
resistance measured, and buffer from the upper and lower compartments removed. 
Glucose uptake was stopped by washing each membrane twice with ice-cold PBS. 
After that, 1 mL of NaOH solution (0.1 mol/L) was added to lyse the cells, and 
aliquots were removed for scintillation counting and protein measurement. 
Scintillation solution (5 mL, Ecoscint XR scintillation solution, National 
Diagnostics) and 0.5 mL of the different test solutions were mixed and analysed by 
scintillation counting using a Packard Liquid Scintillation Analyzer 1600TR. 
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3.1.6 [
3
H] cholesterol uptake 
To determine inhibition of cholesterol uptake, cells were incubated in an F-12 
medium containing 10 nmol/L [1,2-
3
H] cholesterol (PerkinElmer Pty Ltd., 
Melbourne, Australia). The cells were washed twice in F-12 to remove unbound 
[
3
H] cholesterol, and 0.5 mL of 0.1% sodium dodecyl sulphate (SDS) was added to 
each well to solubilise the cells. Three milliliters of Ultima Gold scintillant was 
added, and the radioactivity of the solubilised cells was determined using Wallac 
1410 liquid scintillation counter (Pharmacia, Turku, Finland). For cholesterol efflux 
experiments, cells were washed in F-12 and incubated for 45 min in F-12 
containing 20 nmol/L [
3
H] cholesterol to “load” the cells with cholesterol. Cells 
were then washed twice in F-12 and then incubated (for up to 100 min) containing 
the test samples as shown in the figure legend to determine cholesterol efflux. As a 
positive control, 1% methyl-β-cyclodextrin (MβCD) was used to acutely deplete 
cellular cholesterol. Cells were washed twice in F-12, supernatant was removed, 
and then 0.5 mL of 0.1% SDS was added to solubilise the cells for β counting as 
above.  
 
3.1.7 Cell proliferation 
Cell proliferation was determined using Cell-Titer Blue (Promega, Alexandria, 
Australia) as per manufacturer‟s instructions. Briefly, cells were plated and test 
samples were prepared in as described above. After 48 h, 20 µL of Cell-Titer Blue 
was added, and plates were mixed gently for 5 s and incubated for 2 h at 37 °C in a 
humidified atmosphere of 5% CO2 in air. Fluorescence was then determined with 
excitation and emission wavelengths λex = 550 nm and λem = 615 nm, 
respectively, on a Victor3 multilabel plate counter (PerkinElmer, Waltham, MA).  
  
3.1.8 Oxidative stress 
2‟,7‟-dichlorodihydrofluorescein diacetate (DCF-DA, 5 µM) was used to detect 
intracellular Reactive Oxygen Species (ROS) levels. Then, the cells were washed 
once with PBS and lysed in 3 mL ice-cold 10 mM Tris-HCl buffer (pH 7.4) 
containing 0.2% sodium dodecyl sulphate (SDS). The cell lysates were collected 
and centrifuged at 2000 g for 5 min at 4 °C. The fluorescence of the supernatants 
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was measured using a LS50B PerkinElmer luminescence spectrometer 
(PerkinElmer, Waltham, MA) at an excitation wavelength of 495 nm and an 
emission wavelength of 525 nm. For medium NO quantification, cells were treated 
with or without positive control N(G)-nitro-L-arginine methyl ester (L-NAME) and 
incubated at 37 °C, 5% CO2 for 24 h. The final concentration of solvent in the 
culture medium was maintained at 0.5% (v/v) to avoid solvent toxicity. Cells were 
then stimulated with 100 µg/mL lipopolysaccharide (LPS). After 24 h, cell-free 
supernatants were collected and stored at -80 °C until NO determination using the 
Griess reaction. Absorbance at 540 nm was then measured using an automated 96-
well Varioskan Ascent plate reader (Thermo Electron, Bellefonte, PA). 
 
3.1.9 Lipase assay 
Cells were grown in 6-well plates and 2 mL medium/well. After 48 h incubation, 
the media was removed and the cells were incubated for an additional 12 h in 1 
mL/well of fresh medium containing 25 IU heparin (Leo Pharmaceuticals, Breda, 
The Netherlands). Lipase activity was determined by a triacylglycerol hydrolase 
assay at pH 8.5 in 0.6 M NaCl with a gum acacia-stabilised glycerol [
14
C] trioleate 
emulsion as substrate. Assays were performed for 2 h at 30 °C. Activities are 
expressed as m-units (nmol of free fatty acids released per min). In a total assay 
volume of 125 μL, the release of free fatty acids was linear with time and sample 
volume up to 50 μL for the cell-free medium and 20 μL for the cell lysates. In 
immunoinhibition assays, 40 μL of the cell-free medium or 10 μL of the cell lysates 
was preincubated for 3 h on ice in a total volume of 50 μL with 50 μg of goat anti-
(human HL) IgG. This antibody was raised against human HL partly purified from 
post-heparin plasma. After centrifugation (10 min, 10000 g, 4 °C), 75 μL of 
substrate mixture was added to the supernatant and the residual immunoresistant 
triacylglycerol hydrolase activity was determined. 
  
3.1.10 LDL receptor binding activity 
The effect of apple peel and flesh polyphenolic extracts on HepG2 cell low-density 
lipoprotein (LDL) receptor binding activity was indirectly evaluated by measuring 
the LDL concentration in the cell medium. HepG2 cells were grown in 12-well 
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culture plates, followed by washing PBS and incubation for 24 h in DMEM serum-
free media. The cells were then washed in PBS and incubated for a further 6 h in 
DMEM serum-free media containing fluorescent-labeled Dil-LDL (10 mg/L, 
Biomedical Technologies, Stoughton, MA). The fluorescence of the cell medium 
was measured at 514 nm (excitation) and 550 nm (emission) wavelengths by using 
a LS50B luminescence spectrophotometer (PerkinElmer, Waltham, MA). 
 
3.1.11 Quantification of Apolipoprotein A1 in culture media 
The concentration of Apolipoprotein A1 (ApoA1) in the cell culture media was 
quantified in 96-well plates using an enzyme-linked immunosorbent assay 
(E90519Hu 96 test kit; Gentaur Molecular Products Kampenhout, Belgium), 
according to the manufacturer‟s instructions. 
 
3.1.12 Statistics  
Unless otherwise stated, all the experimental results were expressed as mean ± 
standard deviation (SD) of five determinations. Statistical analysis of data was 
performed by a one-way ANOVA followed by the Tukey-Kramer multiple 
comparison test to evaluate significant differences between a pair of means. P 
values less than 0.05 were regarded as significant. The degree of linear relationship 
between two variables was measured using the Pearson product moment correlation 
coefficient (R). Correlation coefficients (R) were calculated by using Microsoft 
Office Excel application.  
 
3.2 Results and discussion 
3.2.1 Polyphenolic profiling of apple peels and flesh 
The results obtained through HPLC-DAD/ESI-MS
n 
analysis about the polyphenolic 
content in peel and flesh extracts of various apple cultivars are reported in Table 2. 
The qualitative and quantitative composition of apple phytochemicals is complex 
enough, so the attention was focused on some specific compounds, procyanidins, 
rutin and phloridzin, because they are considered as the responsible for some 
important metabolic effects (Tenore et al., 2013a; Tenore et al., 2014).  
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Table 2: Polyphenolic contents in apple peel and flesh extracts determined by 
HPLC-DAD-MS analysis. 
 ANN RD PL F GD 
PEELS      
TP 173.23 ± 2.1 281.73 ± 1.3 152.17 ± 1.1 92.26 ± 2.2 70.14 ± 0.2 
Procyanidins 13.35 ± 1.95 44.21 ± 3.21 13.50 ± 1.98 8.21 ± 1.12 6.03 ± 1.01 
Rutin 27.81 ± 2.10 36.84 ± 3.23 43.84 ± 3.52 17.09 ± 1.78 10.04 ± 1.36 
Phloridzin 42.77 ± 3.23 68.54 ± 3.75 18.23 ± 1.65 16.34 ± 1.44 5.20 ± 1.10 
FLESH      
TP 114.99 ± 1.9 73.40 ± 2.2 68.25 ± 0.8 36.04 ± 1.0 25.12 ± 1.0 
Procyanidins 78.76 ± 3.52 37.70 ± 3.01 52.77 ± 3.24 25.44 ± 2.96 16.01 ± 1.65 
Rutin 10.64 ± 1.21 1.50 ± 0.86 2.49 ± 0.98 1.94 ± 1.78 1.04 ± 0.98 
Phloridzin 2.54 ± 1.85 10.21 ± 2.1 1.60 ± 1.65 1.46 ± 1.31 1.10 ± 0.99 
Values are expressed as mg/100 g FW ± SD (n = 5). 
Results were significantly different at a level of P = 0.001. 
ANN: Annurca; RD: Red Delicious; PL: Pink Lady; F: Fuji; GD: Golden Delicious; 
TP: Total Polyphenols. 
The obtained data confirmed that the level of total phenolic compounds was higher 
in the peels than in the pulp, as reported in earlier works (Tsao et al., 2003; Lamperi 
et al., 2008). Such differences are attributable to the fact that polyphenols are 
produced by plants in order to protect themselves from the attack of pathogens, 
which act mainly on the skin, so their defensive role has significance mainly for the 
peels. Obviously, the values may considerably change if considering different apple 
varieties.  
The richest peel extract was represented by Red Delicious (281.73 mg/100 g FW), 
whereas the poorest one was Golden Delicious (70.14 mg/100 g FW); the other 
apple varieties had a polyphenolic content that was intermediate between these 
values. Red Delicious extract was the richest in phloridzin (68.54 mg/100 g FW) 
and procyanidins (44.21 mg/100 g FW), whereas Pink Lady extract was the richest 
in rutin (43.84 mg/100 g FW). 
Among flesh extracts, the richest one was represented by Annurca (114.99 mg/100 
g FW), whereas the poorest one was Golden Delicious (25.12 mg/100 g FW). The 
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main compounds contained in all the pulp coming from different apple cultivars 
were procyanidins, which ranged from 51.4% to 77.3%. Particularly, Annurca flesh 
extract was the richest in procyanidins (78.76 mg/100 g FW) and possessed the 
highest levels of rutin (10.64 mg/100 g FW), too. Red Delicious extract, instead, 
was the richest in phloridzin (10.21 mg/100 g FW).   
 
3.2.2 Glucose uptake 
The capacity of apple peel and flesh polyphenolic extracts to inhibit glucose uptake 
and transport was tested by using HepG2 cells (human hepatocellular carcinoma). 
The choice of using this type of cells arose from the evidence that malignant cells 
express higher levels of facilitated glucose transporters (GLUTs), through which 
the energy-independent transport of glucose across the plasma membrane occurs. 
The major expression of these transporters is due to an enhanced rate of glycolysis 
by cancer cells. Several glucose transporters have been identified, and they are 
classified into three groups on the basis of sequence similarities and characteristics. 
Glucose transporters are tissue-specific because they reflect the different glucose 
needs of different tissues: liver cells, kidney proximal renal tubule cells, pancreatic 
islet β-cells and intestinal epithelial cells express mainly GLUT2 (Wu et al., 2009).  
The results regarding glucose uptake are shown in Figure 14. The extracts of Red 
Delicious and Annurca peels showed the best glucose uptake inhibition capacity, 
whereas the other samples had less significant activity (Figure 14A). As regards 
flesh extracts, no sample was reported to have significant capacity (Figure 14B) 
(Tenore et al., 2013a). 
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Figure 14: Effect of polyphenolic extracts from apple peels and flesh on glucose uptake by HepG2 
cells. Data are referred to glucose concentration in the cell medium and are the means ± SD (n = 3). 
abcdef
Mean values with different superscript letters are significantly different by the Tukey-Kramer 
multiple comparison test. Results were significantly different at a level of P = 0.001. 
Such an effect has been ascribed to phloridzin, a dihydrochalcone typical of 
Rosaceae plants. In fact, phloridzin is able to reduce glucose uptake by human 
intestinal (Caco-2) cells, thanks to the inhibition of GLUT2, which represents the 
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major apical intestinal sugar transporter when the concentration of glucose is high 
(Manzano et al., 2010). Another work reported that it produces renal glycosuria and 
it blocks intestinal glucose absorption thanks to the inhibition of the Na
+
-glucose 
symporters that are located in the kidney proximal renal tubule and in the mucosa 
of the small intestine (Ehrenkranz et al., 2005). 
The results regarding glucose uptake by HepG2 cells agreed with those regarding 
the content of phloridzin in apple peel and flesh extracts found by HPLC analysis. 
In fact, a statistically significant correlation between phloridzin content and glucose 
uptake inhibition was found both for peels (R = 0.9650) and for flesh (R = 0.9234).  
 
3.2.3 Cholesterol uptake  
The determination of cholesterol uptake was also performed by using HepG2 cell 
line, since it is well known that intestine and liver cells are involved in the 
absorption and the metabolism of lipids.  
The data regarding cholesterol uptake are reported in Figure 15. The results 
revealed that flesh polyphenolic extracts were more active in inhibiting cell 
cholesterol uptake than those ones deriving from peels, and, particularly, the most 
active was Annurca apple flesh extract (Tenore et al., 2013a).  
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Figure 15: Effect of polyphenolic extracts from apple peels and flesh on cholesterol uptake by 
HepG2 cells. Data are referred to cholesterol concentration in the cell medium and are the means ± 
SD (n = 3). 
abcde
Mean values with different superscript letters are significantly different by the 
Tukey-Kramer multiple comparison test. Results were significantly different at a level of P = 0.001. 
Oligomeric procyanidins have been considered as the responsible for this effect. In 
fact, in a previous work, Leifert et al. evaluated the effects on cholesterol uptake by 
polyphenolic extracts obtained from grape seed and red wine and concluded that 
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they would be able to act as β-cyclodextrins, molecules known to bind cholesterol 
(Yu et al., 2006). Procyanidin oligomers would promote the formation of 
complexes similar to β-cyclodextrins, which incorporate cholesterol in a selectively 
and intensively manner. Thus, they would prevent cholesterol uptake and would 
give a false impression of inhibited cholesterol membrane transport in these cells 
(Leifert et al., 2008).  
The results regarding cellular cholesterol uptake agreed with those concerning the 
content in procyanidins of extracts analysed by HPLC-DAD/ESI-MS
n
. In fact, 
procyanidins represented the most abundant polyphenolic compounds contained in 
apple flesh, and Annurca flesh possessed the highest quantity. It was found a good 
linear correlation between the levels of procyanidins contained in the samples and 
the inhibition of cholesterol uptake both for peels (R = 0.9838) and for flesh (R = 
0.9919).  
 
3.2.4 Cell proliferation and oxidative stress 
HepG2 cells were also used in order to evaluate the effects of apple peel and flesh 
polyphenolic extracts on cell proliferation and oxidative stress.  
The results concerning the effects of polyphenolic extracts coming from different 
apple peels are shown in Figure 16. Peel polyphenols revealed to be cytotoxic. In 
particular, Annurca, Red Delicious and Pink Lady peel extracts decreased cell 
proliferation by 48.0%, 62.5% and 37.5%, respectively, by comparison with control 
cells, while Fuji and Golden Delicious peel extracts did not show any significant 
difference compared to control cells (Figure 16A). The lower cell proliferation of 
peel polyphenols coming from Annurca, Red Delicious and Pink Lady may be 
attributed to their capacity to induce the production of ROS and the resulting 
oxidative stress, as corroborated by higher TBARS levels (especially for Annurca 
and Red Delicious) and lower NO levels in the cell medium (Figure 16B and 16C) 
(Tenore et al., 2013a). 
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Figure 16: Effect of polyphenolic extracts from apple peels on HepG2 proliferation (A), oxidative 
stress (B) and on nitric oxide levels in the cell medium (C). Data are the means ± SD (n = 3). 
abcde
Mean values with different superscript letters are significantly different by the Tukey-Kramer 
multiple comparison test. Results were significantly different at a level of P = 0.001. 
It may appear strange that the strong antioxidant polyphenolic compounds could 
exert pro-oxidant effects. Actually, in vitro evidence suggests that these 
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phytochemicals may have different effects depending on the cell line used or on 
their structure and concentration, so they can either scavenge ROS or generate more 
oxidative stress (Choueiri et al., 2012). The occurrence of pro-oxidant effects would 
be directly correlated to the total amount of hydroxyl groups. Specifically, 
quercetin and catechin derivatives, which are characterised by multiple hydroxyl 
groups, significantly increase the production of hydroxyl radicals in a Fenton 
system, resulting to be cytotoxic and pro-apoptotic (Babich et al., 2011; Forester et 
al., 2011).  
Nitric oxide (NO) is a diffusible, transcellular and multifunctional messenger 
involved in the regulation of numerous both physiological and pathological 
conditions. Nitric oxide results from the transformation of L-arginine to L-citrulline 
by the action of the enzyme nitric oxide synthase (NOS) in the presence of O2 and 
NADPH. There are three isoforms of NOS: eNOS, expressed in the vascular 
endothelium; nNOS, present in central and peripheral neurons; iNOS, found in 
several types of cells, such as macrophages and hepatocytes. eNOS and nNOS 
isoforms are constitutively active and their continuous release of NO ensures the 
maintenance of the endothelium in an activated state and the correct functioning of 
the peripheral nervous system, respectively. iNOS isoform produces NO after 
stimulation of immunological or inflammatory pathways and acts as second 
messenger in modulating signalling pathways (Akifusa et al., 2008). When a 
condition of oxidative stress occurs, nitric oxide can combine with superoxide 
radicals (O2·
-
), determining the formation of peroxynitrite (ONOO
-
), which is 
involved in damaging cell constituents and in inducing apoptotic cell death (Chung 
et al., 2001). Thus, lower concentration of NO in cell medium is associated with a 
major consumption of this compound by cells and it is considered as an indicative 
marker of oxidative stress.  
The results concerning the effects of polyphenolic extracts coming from different 
apple flesh are shown in Figure 17. On average, flesh samples revealed to be more 
protective than peels; particularly, Annurca and Red Delicious flesh extracts 
increased cell proliferation by 47.5% and 12.5%, respectively, compared to control 
cells (Figure 17A). This effect was corroborated by lower levels of TBARS and 
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higher levels of NO in the cell medium (Figure 17B and 17C) (Tenore et al., 
2013a).  
 
 
 
Figure 17: Effect of polyphenolic extracts from apple flesh on HepG2 proliferation (A), oxidative 
stress (B) and on nitric oxide levels in the cell medium (C). Data are the means ± SD (n = 3). 
abcdef
Mean values with different superscript letters are significantly different by the Tukey-Kramer 
multiple comparison test. Results were significantly different at a level of P = 0.001. 
a
b
c
d
a
e
0
20
40
60
80
100
120
140
160
Ctrl Annurca RD PL F GD
%
 p
ro
lif
e
ra
ti
o
n
a
b
c
d
e f
0
0,01
0,02
0,03
0,04
0,05
0,06
Ctrl Annurca RD PL F GD
TB
A
R
S 
(µ
M
/µ
g 
p
ro
te
in
)
a
b
c c d e
0
0,5
1
1,5
2
2,5
3
Ctrl Annurca RD PL F GD
N
O
 (
n
m
o
l/
µ
g 
p
ro
te
in
)
A (flesh) 
B (flesh) 
C (flesh) 
 
 
 
40 
 
The best values were obtained for Annurca flesh. Annurca polyphenols decreased 
the physiological intracellular ROS by 33.3%, while the polyphenols obtained from 
the other analysed cultivars had minor effects and ranged from 9.25% to 19.9%. 
Annurca flesh extracts also increased NO release by cells by about five times by 
comparison with the other flesh extracts. Particularly, the latter result is very 
interesting, if considering the important both physiological (vasorelaxation and 
neuronal signal transduction) and pathological (cell apoptosis) actions that this 
compound exerts in different tissues. 
The reasons of the differences found in the behaviour of apple peel and flesh 
polyphenolic extracts of various cultivars relative to cell proliferation and oxidative 
stress have to be sought in the different polyphenolic composition of peels and 
pulp. The most abundant polyphenols in flesh are procyanidins, and oligomeric 
procyanidins have been reported to adsorb to membranes thanks to associations 
with the polar portion of phospholipids and to generate a “flavonoid coat”, which 
would be able to protect against oxidants and other external aggressors. Such a coat 
could limit the access of oxidants to the phospholipid bilayer thanks to the 
formation of a compact structure and it could control the propagation of free radical 
chain reactions that occur in the hydrophobic core membrane (Ugartondo et al., 
2007). 
 
3.2.5 Triglyceride uptake 
The inhibition capacity on triglyceride uptake of apple peel and flesh polyphenolic 
extracts coming from different apple cultivars was evaluated by using HepG2 cell 
line, because of the knowledge of the role of intestine and liver cells in the 
metabolism of lipids.  
The results concerning the effects on triglyceride uptake are shown in Figure 18. As 
regards peels, Red Delicious extract determined an increase in the triglyceride cell 
medium concentration of approximately 854% above control cells, while the other 
polyphenolic extracts led to less relevant effects (Figure 18A). Instead, as regards 
flesh samples, all the extracts determined a reduction in triglyceride deposition, by 
increasing their concentration in the cell medium. The best results were obtained 
with Annurca extract (+2237% than control cells), followed by Pink Lady (+1467% 
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than control cells), Red Delicious (+1012% than control cells), Fuji (+655% than 
control cells) and Golden Delicious (+375% than control cells) extracts (Figure 
18B) (Tenore et al., 2014).  
 
 
Figure 18: Inhibition of HepG2 cell triglyceride uptake by apple peel (A) and flesh (B) 
polyphenolic extracts expressed as remaining triacylglycerols in the medium. Data are the means ± 
SD (n = 5). 
abcdef
Mean values with different superscript letters are significantly different by the 
Tukey–Kramer multiple comparison test (P < 0.05). 
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Procyanidins are considered as the responsible for this effect, because they would 
be able to inhibit in vivo triglyceride uptake (Sugiyama et al., 2007). Moreover, 
oligomeric procyanidins would promote the formation of complexes similar to β-
cyclodextrins, which incorporate triglycerides in a selectively and intensively 
manner. Thus, they would prevent triglyceride uptake and would give a false 
impression of inhibited triglyceride membrane transport in these cells (Leifert et al., 
2008).  
The results regarding cellular triglyceride uptake agreed with the polyphenolic 
profiling obtained by HPLC-DAD/ESI-MS
n
. In fact, procyanidins represented the 
most abundant polyphenolic compounds contained in apple flesh, and Annurca 
flesh had the highest quantity. A good linear correlation between the levels of 
procyanidins contained in the samples and the inhibition of triglyceride uptake both 
for peels (R = 0.9915) and for flesh (R = 0.9395) was found.  
 
3.2.6 Lipase activity  
The incubation of HepG2 cells with apple peel and flesh polyphenolic extracts led 
to the inhibition of triacylglycerol hydrolase, an important enzyme that intervenes 
in lipid digestion.  
The results are shown in Figure 19. Among peels, Red Delicious extract showed the 
highest percentage of inhibition of the enzyme (-30% than control cells), followed 
by Annurca (-8% than control cells), Pink Lady (-7% than control cells), Fuji (-4% 
than control cells) and Golden Delicious (not detectable) extracts (Figure 19A). As 
regards flesh extracts, the percentage of inhibition for Annurca was higher than 
those found in other apple peel and flesh extracts (-55% than control cells). The 
other flesh extracts showed the following percentages of inhibition compared to 
control cells: Pink Lady, -30%; Red Delicious, -21%; Fuji, -14% and Golden 
Delicious, -9% (Figure 19B) (Tenore et al., 2014).  
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Figure 19: Inhibition of lipase activity in HepG2 cells by apple peel (A) and flesh (B) polyphenolic 
extracts. Data are the means ± SD (n = 5). 
abcdef
Mean values with different superscript letters are 
significantly different by the Tukey-Kramer multiple comparison test (P < 0.05). 
An earlier work reported that apple polyphenolic extracts are able to inhibit in vitro 
pancreatic lipase activity in a dose-dependent manner and to reduce in vivo 
triglyceride absorption (Sugiyama et al., 2007). In particular, oligomeric 
procyanidins are considered as the apple polyphenols responsible for the inhibition 
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of this enzyme, because they have been reported to interact with proteins thanks to 
hydrophobic effects, hydrogen bonds and proline residues (Haslam, 1996). 
Specifically, procyanidins characterised by a higher degree of polymerization 
would be associated with an increase in the inhibition of pancreatic lipase, which 
reached its maximal level with pentameric or greater procyanidins (Sugiyama et al., 
2007).  
The results regarding the inhibition of pancreatic lipase agreed with the procyanidin 
content found in the extracts through HPLC-DAD/ESI-MS
n 
analysis. In fact, 
procyanidins represented the most abundant polyphenolic compounds contained in 
apple flesh, and Annurca flesh expressed the highest quantity. A good linear 
correlation between the levels of procyanidins contained in the samples and the 
inhibition of enzyme activity both for peels (R = 0.9727) and for flesh (R = 0.9903) 
was found.  
The inhibition of pancreatic lipase would be associated with a reduced hydrolysis of 
dietary lipid esters and the resulting absorption of fatty acids (Sbarra et al., 2005), 
even if no data on hepatic cells are now available.  
The obtained data showed a good linear correlation between the inhibition of 
triacylglycerol hydrolase activity and triglyceride uptake both for peels (R = 
0.9689) and for flesh (R = 0.9843). 
 
3.2.7 Low-density lipoprotein (LDL) receptor binding activity 
The incubation of HepG2 cells with apple peel and flesh polyphenolic extracts 
obtained from different cultivars led to an enhancement in binding activity of low-
density lipoprotein (LDL) receptor, that was evaluated indirectly by measuring the 
LDL concentration.  
The results are shown in Figure 20. Among peels, Red Delicious extract was the 
most effective in increasing the binding activity of LDL receptor (-26% than 
control cells) (Figure 20A). As regards flesh, instead, Annurca extract was the most 
effective and showed the highest results (-46% than control cells), followed by Pink 
Lady (-30% than control cells), Red Delicious (-20% than control cells), Fuji (-6% 
than control cells) and Golden Delicious (not detectable) (Figure 20B) (Tenore et 
al., 2014).  
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Figure 20: Enhancement of HepG2 cell low-density lipoprotein (LDL) receptor binding activity by 
apple peel (A) and flesh (B) polyphenolic extracts expressed as remaining LDL in the medium. Data 
are the means ± SD (n = 5). 
abcdef
Mean values with different superscript letters are significantly 
different by the Tukey-Kramer multiple comparison test (P < 0.05). 
Procyanidins are the compounds that may be responsible for such an effect. In fact, 
these molecules are constituted by catechin and epicatechin monomers, which have 
already been reported to enhance LDL receptor binding activity of HepG2 cells in a 
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dose-dependent manner, by facilitating the active SREBP-1 (Sterol Regulatory 
Element Binding Protein-1) transcription factor form. Thus, procyanidins would act 
in a manner similar to that of green tea catechins (Bursill et al., 2006). 
The results regarding the enhancement of LDL receptor binding activity agreed 
with those regarding the procyanidin content in apple peel and flesh samples. In 
fact, procyanidins represented the major component contained in apple flesh, and, 
particularly, Annurca flesh had the highest quantity. A good linear correlation 
between the levels of procyanidins contained in the samples and the LDL receptor 
binding up-regulation was registered both for peels (R = 0.9488) and for flesh (R = 
0.9887). 
 
3.2.8 Apolipoprotein A1 (ApoA1) expression 
The incubation of HepG2 cells with apple peel and flesh polyphenolic extracts led 
to an increased expression of Apolipoprotein A1 (ApoA1), which is the major 
protein component of HDL particles. HDL particles are involved in the cholesterol 
transport from extrahepatic tissues to the liver, in order to process or excrete 
cholesterol in bile acids. Moreover, ApoA1 activates the enzyme LCAT 
(lecithin:cholesterol acyltransferase), so it is essential for the reverse cholesterol 
pathway (Jonas, 1998).   
The results are shown in Figure 21. Among peels, Red Delicious extract was the 
most effective in increasing the expression of Apolipoprotein A1 (+35.7% than 
control cells) (Figure 21A). As regards flesh, instead, Annurca extract was more 
effective than other apple peel and flesh extracts (+71.4% than control cells), 
followed by Pink Lady (+54.3% than control cells), Red Delicious (+21.4% than 
control cells), Fuji (not detectable) and Golden Delicious (not detectable) extracts 
(Figure 21B) (Tenore et al., 2014).  
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Figure 21: Enhancement of HepG2 cell ApoA1 protein expression by apple peel and flesh 
polyphenolic extracts expressed as ApoA1 protein concentrations in the medium. Data are the means 
± SD (n = 5). 
abcdef
Mean values with different superscript letters are significantly different by the 
Tukey-Kramer multiple comparison test (P < 0.05). 
It has been reported that several polyphenolic compounds may increase ApoA1 
levels in HepG2 cells (Yasuda et al., 2011) and tea catechins are able to enhance 
HDL plasma levels both in animals (hyperlipidemic rats) and humans (patients with 
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obesity and metabolic syndrome) (Gong et al., 2010; Basu et al., 2010). Moreover, 
the enzyme LCAT would be more active after the interaction of (+)-catechin and 
procyanidins with ApoA1 and the resulting change of its conformation (Jonas, 
1998).  
A good linear correlation between the levels of procyanidins contained in the 
samples and the increase in ApoA1 cell expression was registered both for peels (R 
= 0.8946) and for flesh (R = 0.9772). 
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CHAPTER 4 
In vitro evaluation of bioaccessibility, bioavailability and plasma 
protein interaction of digested apple peel and flesh polyphenols 
4.1 Materials and methods 
4.1.1 Reagents and standards 
All chemicals and reagents used were either analytical-reagent or HPLC grade. The 
water was treated in a Milli-Q water purification system (Millipore, Bedford, MA) 
before use. The standards used for the identification and quantification of phenolic 
acids and flavonoids were: chlorogenic acid, (+)-catechin, (-)-epicatechin, 
isorhamnetin, myricetin, phloretin, phloridzin (phloretin-2-O-glucoside), 
procyanidin B2, quercetin, quercitrin (quercetin-3-O-rhamnoside), rutin (quercetin-
3-O-rutinoside), isoquercitrin (quercetin-3-O-glucoside), hyperin (quercetin-3-O-
galactoside) and cyanidin-3-O-galactoside chloride (Sigma Chemical Co., St. 
Louis, MO). Chemicals and reagents used to simulate the gastrointestinal digestion 
and interaction with plasma proteins were: potassium chloride (KCl), potassium 
thiocyanate (KSCN), monosodium phosphate (NaH2PO4), sodium sulphate 
(Na2SO4), sodium chloride (NaCl), sodium bicarbonate (NaHCO3), urea, α-
amylase, hydrochloric acid (HCl), pepsin, pancreatin, bile salts, human serum 
albumin (HSA, ≥ 97.0%), high-density lipoprotein (HDL, ≥ 95.0%), low-density 
lipoprotein (LDL, ≥ 95.0%) and very low-density lipoprotein (VLDL, ≥ 95.0%) 
(Sigma Chemical Co., St. Louis, MO). Acetonitrile and methanol were of HPLC 
grade (Carlo Erba, Milano, Italy). 
 
4.1.2 Fruit collection and sample preparation 
Annurca (Malus pumila Miller cv Annurca) apple fruits were collected in Valle di 
Maddaloni (Caserta, Italy) in October when fruits had just been harvested (green 
peel). Fruits were reddened, following the typical treatment (Lo Scalzo et al., 2001) 
for about 30 days, and then analysed. Other four apple varieties analysed in this 
study, Red Delicious (RD) (Malus pumila Miller cv Red Delicious), Pink Lady 
(PL) (Malus pumila Miller cv Pink Lady), Fuji (F) (Malus pumila Miller cv Fuji) 
and Golden Delicious (GD) (Malus pumila Miller cv Golden Delicious), were 
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purchased in a local supermarket. Lyophilised apple peels and flesh (10 g) were 
treated with 100 mL of a methanol/water mixture (80:20, v/v) acidified with 0.5% 
formic acid for 24 h at 4 °C in order to extract phenolic compounds. After 
centrifugation, the supernatant was slowly filtered and purified through an 
Amberlite XAD-2 column packed as follows: 10 g of resin (pore size 9 nm; particle 
size 0.3-1.2 mm; Supelco, Bellefonte, PA) was soaked in methanol, stirred for 10 
min and then packed into a glass column (10 x 2 cm). The column was washed with 
100 mL of acidified water (pH 2) and 50 mL of deionised water in order to remove 
sugar and other polar compounds. The adsorbed phenolic compounds were 
extracted from the resin by elution with 100 mL of methanol, which was evaporated 
by flushing with nitrogen. The polyphenolic extracts were stored at -80 °C until 
analysis.  
 
4.1.3 In vitro gastrointestinal digestion 
In vitro gastrointestinal digestion was performed according to a procedure 
described previously (Raiola et al., 2012), with slight modification. In vitro 
gastrointestinal digestion was distinguished into different steps: salivary, gastric 
and duodenal digestive steps. For the salivary digestion, apple samples (20 g) were 
mixed with 6 mL of artificial saliva consisting of: potassium chloride (KCl, 89.6 
g/L), potassium thiocyanate (KSCN, 20 g/L), monosodium phosphate (NaH2PO4, 
88.8 g/L), sodium sulphate (Na2SO4, 57.0 g/L), sodium chloride (NaCl, 175.3 g/L), 
sodium bicarbonate (NaHCO3, 84.7 g/L), urea (25.0 g/L) and α-amylase (290 mg). 
The pH of the solution was adjusted to 6.8 with HCl 0.1 N. Then, the mixture was 
introduced in a plastic bag containing 40 mL of water and homogenised in a 
Stomacher 80 Microbiomaster (Seward, Worthing, UK) for 3 min. Immediately, 0.5 
g of pepsin (14800 U) dissolved in HCl 0.1 N was added, the pH was adjusted to 
2.0 with HCl 6 N, and then incubated at 37 °C in a Polymax 1040 orbital shaker 
(250 rpm) (Heidolph, Schwabach, Germany) for 2 h. After the gastric digestion, the 
duodenal step was simulated as follows: the pH was increased to 6.5 with NaHCO3 
0.5 N and then 5 mL of a mixture constituted by pancreatin (8.0 mg/mL) and bile 
salts (50.0 mg/mL) (1:1, v/v), dissolved in 20 mL of water, was added and 
incubated at 37 °C in an orbital shaker (250 rpm) for 2 h. After each step of 
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digestion, 10 mL of the obtained extract were centrifuged at 4000 rpm and 4 °C for 
1 h: before each following step, the digestion procedure was started over again. To 
determine the polyphenolic profile, the supernatants were extracted with a mixture 
of acetonitrile-water (84:16; v/v) and then analysed by HPLC. 
 
4.1.4 Cell culture and in vitro study of polyphenolic transepithelial 
transport 
Human colon carcinoma cells Caco-2 (HTB-37) were obtained from the American 
Type Culture Collection (LGC Promochem, Molsheim, France). Cells were 
cultured routinely in HEPES buffered Dulbecco‟s Modified Eagle‟s Medium 
(DMEM) with 4.5 g/L glucose and supplemented with 12.5% heat-
decomplemented fetal calf serum (FCS), 1% nonessential amino acids, 5 mM L-
glutamine, 40 U/mL penicillin, 100 µg/mL gentamycin and 40 µg/mL streptomycin 
(DMEMc). Cells were maintained at 37 °C in a humidified atmosphere of CO2/air 
(5:95) and passaged every 7 days by trypsinisation. They were seeded in transwells 
at 6 x 10
4 
cells/cm
2
. The medium (15 mL DMEM containing 10% FCS) was 
changed every 2 days until cells reached confluence (7-8 days). The integrity of the 
monolayers was evaluated by measurement of the transepithelial electrical 
resistance (TEER) using a Millicell-ERS device (Millipore, Zug, Switzerland) 
before and after the treatments. To evaluate transepithelial permeability, medium 
was removed from the apical and basal sides of the cultures and replaced by 2 mL 
of the transport solution consisting of Hanks‟ balanced salt solution (HBSS) and 
intestinal apple polyphenols, and pH was adjusted to 6 or 7.4. After 4 h of 
incubation at 37 °C, apical and basal solutions were collected and in order to 
determine the polyphenolic profile, aliquots (5 mL) were immediately mixed with 1 
mL of methanol and filtered on 0.45 µm Millex-HV filter units. Samples were 
stored at -20 °C until HPLC analysis. 
 
4.1.5 In vitro study of plasma protein interaction with polyphenols 
The in vitro transepithelial permeated polyphenols were added to plasma protein 
solutions simulating, each one, the average fasting plasma protein concentrations. 
The basic composition of plasma protein solutions consisted in 20 mM HEPES (pH 
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7.5), 0.9% NaCl, 0.5 M NaHCO3. Each plasma protein solution was constituted by: 
human serum albumin (HSA, 42 mg/mL), high-density lipoprotein (HDL, 1450 
µg/mL), low-density lipoprotein (LDL, 780 µg/mL) and very low-density 
lipoprotein (VLDL, 120 µg/mL). Polyphenols were incubated with plasma proteins 
for 30 min at 37 °C to allow equilibration. Then, the samples were centrifuged at 25 
°C for 30 min at 14000 g. The supernatant containing the free polyphenolic fraction 
was collected and subjected to HPLC analysis. 
 
4.1.6 HPLC-DAD/ESI-MS
n 
analysis 
HPLC separation and quantification of phenolic compounds in apple peel and flesh 
extracts and samples obtained from in vitro digestion, transepithelial permeation, 
and plasma protein binding experiments were performed according to previous 
studies with some modifications (Mari et al., 2010). The identification of phenolic 
compounds was possible by recording chromatograms at different wavelengths, 280 
nm for flavonols, procyanidins, dihydrochalcones and hydroxycinnamic acids, and 
500 nm for anthocyanins and by comparing spectra and retention times with those 
of commercial standards and with those reported in previous works (Mari et al., 
2010). Elution conditions consisted in 2% acetic acid (solvent A) and 0.5% acetic 
acid in acetonitrile and water (50:50, v/v) (solvent B) gradient at a flow rate of 1.0 
mL/min. The column selected was a Hypersil BDS C18 column (250 mm x 4.6 
mm, 5 µm) (Thermo, Bellefonte, PA). Analyses were run on a Finnigan HPLC 
system (Thermo Electron Corporation, San Jose, CA) provided with photodiode 
array detector (DAD). The gradient conditions were: 0-5 min, 10% B; 55 min, 55% 
B; 65 min, 95% B, followed by 5 min of maintenance. The identity of phenolic 
acids and flavonoids was confirmed with LC-ESI/MS/MS experiments and data 
were compared with those of commercial standards and with those reported in 
previous works (Mari et al., 2010). The same chromatographic conditions were 
applied to a HP1100 HPLC system (Agilent, Palo Alto, CA) coupled to a PE-Sciex 
API-2000 triple-quadrupole mass spectrometer (AB Sciex, Warrington, UK) 
equipped with a Turbospray (TSI) source. Individual phenols were separated on a 
Hypersil BDS C18 column (250 mm x 2.1 mm, 5 µm) (Thermo Electron, 
Bellefonte, PA) at a flow rate of 200 µL/min. Mass spectra were recorded from m/z 
 
 
 
53 
 
= 50 to 1500, in both negative and positive ionisation mode. For negative ion mode, 
the capillary voltage was set at -13 V, the spray voltage was at 4.5 kV and the tube 
lens offset was at -15 V, while in positive ion mode, the capillary voltage was set at 
13 V, the spray voltage was at 5 kV and the tube lens offset was at -35 V. The 
capillary temperature was 275 °C. Data were acquired in MS, MS/MS and MS
n 
scanning modes. 
 
4.1.7 Statistics 
All the experimental results were expressed as mean ± standard deviation (SD) of at 
least five replications. Statistical analysis of data was performed by the Student‟s t 
test or two-way ANOVA followed by the Tukey-Kramer multiple comparison test 
to evaluate significant differences between a pair of means. The level of 
significance (α-value) was 95% in all cases (P < 0.05). The degree of linear 
relationship between two variables was measured using the Pearson product 
moment correlation coefficient (R). Correlation coefficients (R) were calculated by 
using Microsoft Office Excel application.  
 
4.2 Results and discussion 
As already reported, the parameters studied were bioaccessibility, bioavailability 
and interactions with plasma proteins (Tenore et al., 2013b). Bioaccessibility is 
considered as the nutrient fraction that is extracted from the food matrix in the 
gastrointestinal tract and that becomes available for the absorption (Tagliazucchi et 
al., 2010), while bioavailability is the fraction that reaches the systemic circulation 
and that is available for the action (Manach et al., 2004). The amount of the 
considered polyphenols before digestion of apple peel and flesh is reported in 
Figure 22. 
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Figure 22: Polyphenolic profile of apple peel and flesh extracts. Polyphenolic contents are 
expressed as mg/100 g FW ± SD (n = 5). Means are significantly different by the Tukey-Kramer 
multiple comparison test (P < 0.05).  
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4.2.1 Bioaccessibility after salivary digestion 
The results regarding the bioaccessibility after salivary digestion are shown in 
Figure 23. The first digestive step revealed to be very important for the simulated 
digestive extraction process of apple polyphenols. Procyanidins, rutin and 
phloridzin coming from apple peels and flesh were detected in this step at levels of 
about 35.0%, 35.1% and 27.3%, respectively, of the undigested samples. As 
expected on the basis of the values obtained before the in vitro digestion process, 
experimental results showed for Red Delicious and Pink Lady peels the greatest 
bioaccessibility in phloridzin (18.71 mg/100 g FW) and rutin (15.39 mg/100 g FW), 
respectively, and for Annurca pulp the best bioaccessibility in procyanidins (27.57 
mg/100 g FW). 
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Bioaccessibility of apple peel and flesh polyphenols after salivary digestion 
 
 
 
 
Figure 23: Salivary bioaccessibility of polyphenols from apple peels and flesh. Polyphenolic 
contents are expressed as mg/100 g FW ± SD (n = 5). Means are significantly different by the 
Tukey-Kramer multiple comparison test (P < 0.05). 
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Salivary digestion represents a key step in a simulated in vitro gastrointestinal 
digestion because it is well known that the epithelium of oral mucosa is highly 
vascularised and allows both polar and hydrophobic molecules to be absorbed and 
to reach rapidly the systemic circulation, without the passage through the 
gastrointestinal tract. Thus, since a lot of molecules, both nutrients and non-
nutrients, are sensitive to pH variations and/or are poorly absorbed by the 
epithelium of the intestinal mucosa, good extraction processes at this level may be 
preliminary to a better bioavailability of such compounds, because they cannot be 
degraded in the stomach and/or destroyed in the intestine and/or subjected to 
metabolism by the liver (Oulianova et al., 2007). Moreover, it has been reported 
that procyanidins and condensed tannins may inhibit some digestive enzymes, such 
as α-amylase, which degrades starch to dextrins. Thus, these molecules may act as 
antinutritional compounds and for procyanidin-rich foods mastication is more 
important than salivary enzymes in defining their bioaccessibility (Gonçalves et al., 
2011). 
 
4.2.2 Bioaccessibility after gastric digestion 
The data regarding the bioaccessibility after the gastric phase are reported in Figure 
24. The gastric phase revealed an increase in the bioaccessibility of procyanidins, 
rutin and phloridzin compared to salivary step (about, +5.1%, +30.5% and +11.5%, 
respectively), both for peels and for flesh. As expected on the basis of the values 
obtained before the in vitro digestion process, experimental results showed for Red 
Delicious and Pink Lady peels the greatest bioaccessibility in phloridzin (26.59 
mg/100 g FW) and rutin (28.76 mg/100 g FW), respectively, and for Annurca flesh 
the best bioaccessibility in procyanidins (31.58 mg/100 g FW). 
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Bioaccessibility of apple peel and flesh polyphenols after gastric digestion 
  
 
 
 
Figure 24: Gastric bioaccessibility of polyphenols from apple peels and flesh. Polyphenolic contents 
are expressed as mg/100 g FW ± SD (n = 5). Means are significantly different by the Tukey-Kramer 
multiple comparison test (P < 0.05).  
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Greater values of accessible polyphenols in the gastric phase than in the salivary 
phase highlight two important aspects: firstly, there is a continuation of extractive 
processes of polyphenolic compounds from food matrix; secondly, polyphenols are 
stable at highly acid pH in the stomach.  
However, our results were partially in contrast with some previously reported. As 
regards rutin and phloridzin, they have already been reported to be resistant enough 
to acid hydrolysis and to reach the intestine in their native form, without any 
transformation to corresponding aglycones (Manach et al., 2004; Bouyaed et al., 
2012). As regards procyanidins, previous studies reported that they are sensitive to 
gastric acid pH and are degraded to their monomers within few hours (Zhu et al., 
2002). Nevertheless, these data refer mainly to procyanidin B1, B2 and B5, which 
are dimeric compounds, but apple extracts are rich in complex mixtures of 
procyanidins characterised by a higher degree of polymerization (such as trimers, 
tetramers and pentamers) (Mari et al., 2010). Earlier in vivo studies reported that 
cocoa procyanidins, which exhibit a higher degree of polymerization respect to 
dimeric compounds, would be more resistant to the pH of the stomach and would 
not be degraded into the corresponding monomers in such a little time (Rios et al., 
2002). 
 
4.2.3 Bioaccessibility after intestinal digestion 
The results concerning the intestinal bioaccessibility are shown in Figure 25. After 
intestinal digestion, the levels of procyanidins and phloridzin were higher (about, 
+16.0% and +6.6%, respectively), whereas rutin levels were lower (approximately, 
-18.6%) than those found in gastric step. As expected on the basis of the values 
obtained before the in vitro digestion process, experimental results showed for Red 
Delicious and Pink Lady peels the greatest bioaccessibility in phloridzin (31.12 
mg/100 g FW) and rutin (20.6 mg/100 g FW), respectively, and for Annurca flesh 
the best bioaccessibility in procyanidins (44.18 mg/100 g FW).  
 
 
 
 
 
 
 
60 
 
Bioaccessibility of apple peel and flesh polyphenols after intestinal digestion 
 
 
 
 
Figure 25: Intestinal bioaccessibility of polyphenols from apple peels and flesh. Polyphenolic 
contents are expressed as mg/100 g FW ± SD (n = 5). Means are significantly different by the 
Tukey-Kramer multiple comparison test (P < 0.05).  
7.49
24.8
7.57
4.60 3.38
13.07
17.31
20.6
8.03
4.72
19.42
31.12
8.28
7.41
2.36
0
5
10
15
20
25
30
35
Annurca RD PL F GD
m
g/
1
0
0
 g
 F
W
Procyanidins
Rutin
Phloridzin
44.18
21.14
29.60
14.27
8.98
5.00
0.70 1.17 0.91
0.49
1.15
4.63
0.73 0.66 0.50
0
5
10
15
20
25
30
35
40
45
50
Annurca RD PL F GD
m
g/
1
0
0 
g 
FW
A (peels) 
B (flesh) 
 
 
 
61 
 
Our results were in agreement with previous studies as regards intestinal 
bioaccessibility of rutin and phloridzin (Bouayed et al., 2012). Instead, the results 
regarding the intestinal bioaccessibility of procyanidins were in contrast with some 
previously reported. In fact, Zhu et al. highlighted the complete degradation of 
procyanidin B2, a dimeric compound, in the intestinal medium into unknown 
products (Zhu et al., 2002). However, similarly to what stated for the gastric phase, 
procyanidins with a higher degree of polymerization (for example, trimers, 
tetramers and pentamers) would be more stable than dimeric compounds. 
 
4.2.4 Bioavailability of permeated polyphenols 
In order to study the bioavailability of polyphenols coming from apple peels and 
flesh, single layers of Caco-2 cells were used. They were treated with apple peel 
and flesh polyphenols coming from intestinal digestion only after the evaluation of 
their biocompatibility through MTT assay. The choice of using this type of cell 
line, which is considered as a model of absorption in the small intestine, arose from 
the evidence that experiments performed by using a semipermeable cellulose 
membrane do not consider other mechanisms involved in the absorption of 
polyphenols. In fact, dialysis bags simulate only the intestinal passive diffusion, but 
polyphenols can be absorbed by enterocyte bilayer also through facilitated diffusion 
and active transport. As reported in Chapter 2, most part of glycosides are 
hydrolysed by specific enzymes and only the aglycone mojety can be absorbed in 
the small intestine; only specific glucosides can be absorbed without undergoing 
hydrolysis process, through the Na
+
-dependent glucose transporter (SLGT1) 
(Manach et al., 2004).   
Rutin is a quercetin glycoside, constituted by the flavonol quercetin and the 
disaccharide rutinose. It has been reported that polyphenols linked to a rhamnose 
mojety reach the colon and are hydrolysed by rhamnosidases before absorption 
(Graefe et al., 2001). Phloridzin is a phloretin glucoside, constituted by phloretin 
and glucose. It has been reported that there is a first step of extracellular hydrolysis 
by the enzyme phloridzin hydrolase present in the brush-border membrane; then, 
there is a second step of passive diffusion of aglycone mojety across the brush 
border (Day et al., 2000). As regards procyanidins, it has been reported they are 
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poorly absorbed in their native form because of their high molecular weight 
(Déprez et al., 2001). 
Our experimental results showed that all the considered polyphenols are scarcely 
absorbed, in contrast with a previous study (Bouyaed et al., 2012), whose results 
may appear overestimated. The aliquots of permeated rutin, phloridzin and 
procyanidins were about 5.21%, 5.16% and 6.7%, respectively, of their native 
patterns and about 11.1%, 11.4% and 12.0%, respectively, of their intestinal levels. 
In spite of such scarce values, these molecules may accumulate in the intestine and 
exert important local activity. First of all, their strong antioxidant capacity could 
protect the gut from oxidising agents, to which it is highly exposed, and so they 
could prevent the onset of various diseases, such as inflammation and cancer 
(Halliwell et al., 2000). Furthermore, the high molecular weight procyanidins may 
lead to a decrease in cholesterol uptake, by acting as β-cyclodextrins and forming 
micelle-like complexes in which cholesterol is selectively and intensively 
incorporated (Leifert et al., 2008). 
All the data are shown in Table 3 and in Figure 26. 
Table 3: Percentages of bioavailability of polyphenols from apple peels and flesh. 
 Rutin Phloridzin Procyanidins 
Bioavailability 
(%) vs native 
patterns 
5.21 5.16 6.7 
Bioavailability 
(%) vs intestinal 
levels 
11.1 11.4 12.0 
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Bioavailability of apple peel and flesh polyphenols after intestinal digestion 
 
 
 
Figure 26: Bioavailability of polyphenols from apple peels and flesh evaluated by using single 
layers of Caco-2 cells as a model of absorption in the small intestine. Polyphenolic levels are 
expressed as mg/100 g FW ± SD (n = 5). Means are significantly different by the Tukey-Kramer 
multiple comparison test (P < 0.05).  
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4.2.5 Interaction with plasma proteins 
Finally, the interactions of permeated polyphenols coming from apple peel and 
flesh with plasma proteins were evaluated. All the considered polyphenols showed 
a generally very high percentage of binding to plasma proteins, on average 93%. 
Rutin and phloridzin interacted chiefly with albumin (about 56.5% and 55.9%, 
respectively), as already reported in previous studies (Manach et al., 2004; Xiao et 
al., 2012), whereas procyanidins preferentially bound to HDLs (about 58.7%). 
Polyphenolic compounds also bound significantly to LDLs (on average, 16.2-
19.6%), but they interacted scarcely with VLDLs (on average, 0.4-0.5%). 
The experimental results are shown in Table 4. 
Table 4: Percentages of bioavailable apple polyphenolic compounds bound to 
plasma proteins. 
 HSA HDL LDL VLDL 
Procyanidins 18.1 ± 0.9 58.7 ± 1.6 16.2 ± 1.1 0.4 ± 0.3 
Rutin 56.5 ± 1.5 17.1 ± 1.0 19.6 ± 0.3 0.5 ± 0.1 
Phloridzin 55.9 ± 2.0 16.8 ± 1.2 18.9 ± 0.8 0.4 ± 0.5 
Data are mean values ± SD (n = 5) of polyphenols from peels and flesh of apple samples. 
Means are significantly different by the Tukey-Kramer multiple comparison test (P < 
0.05). 
HSA: Human Serum Albumin; HDL: High-Density Lipoprotein; LDL: Low-Density 
Lipoprotein; VLDL: Very Low-Density Lipoprotein. 
Protein-polyphenol interactions may be either reversible or irreversible; the type of 
binding depends on several factors, such as pH, temperature and concentration of 
both proteins and ligands (Xiao et al., 2012). However, the consequences of these 
interactions are not clear, but they would generally affect biological activities, 
leading to different effects (Manach et al., 2004; Xiao et al., 2012). 
It has been demonstrated that procyanidins form a stable complex with protein 
ApoA1, the main protein component of HDL particles (Brunet et al., 2002). Protein 
ApoA1 is involved in the reverse cholesterol pathway because it activates the 
enzyme LCAT, that would be more active after the interaction of protein ApoA1 
with procyanidins or their monomers and the resulting change of its conformation 
(Jonas, 1998). Thus, the interaction between procyanidins and HDLs suggests a 
possible role of procyanidins in the reverse transport and metabolism of cholesterol.  
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Moreover, the binding between polyphenols and LDLs may have an important role 
in the protection of cardiovascular system from oxidising agents and atherosclerosis 
(Manach et al., 2004). 
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CHAPTER 5 
In vivo effects on plasma levels of TC, LDL-C and HDL-C after 
regular consumption of various apple cultivars 
5.1 Materials and methods 
5.1.1 Apple samples 
Annurca (Malus pumila Miller cv Annurca) apple fruits (each weighing about 100 
g) were collected in Valle di Maddaloni (Caserta, Italy) in October, when fruits had 
just been harvested (green peel). Fruits were reddened following the typical 
treatment (Lo Scalzo et al., 2001) for about 30 days and then analysed. Four other 
apple varieties (each weighing about 200 g) analysed in this study, Red Delicious 
(RD) (Malus pumila Miller cv Red Delicious), Granny Smith (GS) (Malus pumila 
Miller cv Granny Smith), Fuji (F) (Malus pumila Miller cv Fuji) and Golden 
Delicious (GD) (Malus pumila Miller cv Golden Delicious), were purchased from a 
local supermarket. 
 
5.1.2 Study population and protocol 
The study is listed on the ISRCTN registry with ID ISRCTN15653394. Study 
participants were recruited by the Samnium Medical Cooperative (Benevento, 
Italy). Patients were enrolled in November 2015. Patients aged 18-83 years were 
eligible for enrolment if they had the following values of serum cholesterol 
parameters at baseline: total cholesterol (TC), 200-260 mg/dL; high-density 
lipoprotein cholesterol (HDL-C), 30-45 mg/dL; low-density lipoprotein cholesterol 
(LDL-C), 189-206 mg/dL. The subjects were asked to keep their dietary habits 
unchanged throughout the entire study. 
Exclusion criteria were: smoking, obesity (body mass index - BMI - > 30 kg/m
2
), 
diabetes, hepatic disease, renal disease, heart disease, family history of chronic 
diseases, drug therapy or supplement intake for hypercholesterolemia, drug therapy 
or supplement intake containing apple polyphenols, heavy physical exercise (> 10 h 
per week), pregnant women, women suspected of being pregnant, women who 
hoped to become pregnant, breastfeeding women, birch pollen allergy, use of 
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vitamin/mineral supplements 2 weeks prior to entry into the study and donation of 
blood less than 3 months before the study.  
The subjects received oral and written information concerning the study before they 
gave their written consent. Protocol, letter of intent of volunteers and synoptic 
document about the study were submitted to the Scientific Ethics Committee of AO 
Rummo Hospital (Benevento, Italy). The study was approved by the committee 
(protocol 14307) and carried out in accordance with the Helsinki Declaration of 
1964 (as revised in 2000). The subjects were asked to make records in an intake-
checking table for the intervention study and side effects in daily reports. The study 
was a monocentric, randomised, single-blind, placebo-controlled trial, conducted at 
the Samnium Medical Cooperative (Benevento, Italy).  
The study duration was 16 weeks: the same group underwent 4 weeks of placebo 
treatment, consisting of the habitual diet without apples, followed by 8 weeks of 
intervention study and 4 weeks of follow-up. Both the examinations and the 
intervention study were performed in an outpatient setting. Clinic visits and blood 
sampling were performed after 12 h of fasting at weeks 0, 4, 8, 12 and 16. Subjects 
were informed not to drink alcohol or perform hard physical activity 48 h prior to 
blood sampling. All blood samples were taken in the morning and immediately 
after measurement of heart rate and blood pressure. Blood samples were collected 
in 10-mL EDTA-coated tubes (Becton-Dickinson, Plymouth, UK) and plasma was 
isolated by centrifugation (20 min, 2200 g, 4 °C). All samples were stored at -80 °C 
until analysis. Plasma TC, HDL-C and LDL-C levels were determined using 
commercially available kits from Diacron International (Grosseto, Italy). Analyses 
were performed on a Diacron International Free Carpe Diem, and intra- and inter-
day variations were 1.4% and 1.6% for TC, 1.6% and 2.2% for LDL-C, and 2.0% 
and 2.3% for HDL-C, respectively. In addition to these five meetings, six 
standardised telephone interviews were performed every 14 days starting from the 
first meeting, to verify compliance and increase protocol adherence. These 
interviews reminded patients to complete their intake-checking table for the 
intervention study and to record any discontinuation or adverse events they might 
have experienced in the meantime (which were also documented regularly on the 
case report forms during each telephone and clinic visit). 
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All patients underwent a standardised physical examination, assessment of medical 
history (for up to 5 years before enrolment), laboratory examination, measurement 
of blood pressure and heart rate, and evaluation of BMI. At each clinic visit, 
patients had to complete three self-administered questionnaires on quality-of-life 
aspects, and their diaries were checked for data completeness and quality of 
documentation to ensure patient comprehension of the diary items. 
 
5.1.3 Randomisation, concealment and blinding 
A total of 250 eligible patients were randomly assigned to five groups in order to 
receive apple samples. On the first day of week 5 and once a week during the 
following 8 weeks, subjects were supplied with apples to be consumed during the 
following week. Apples were coded with different colours and given in random 
order. The code was not broken until all analyses were completed and the results 
were analysed statistically. If a patient dropped out before receiving apples, he or 
she was replaced by the next eligible patient enrolled at the same centre. The 
concealed allocation was performed by an Internet-based randomisation schedule, 
stratified by study site. The random number list was generated by an investigator 
with no clinical involvement in the trial. Patients, clinicians, core laboratories and 
trial staff (data analysts, statisticians) were blind to treatment allocation. 
 
5.1.4 Study treatments 
A group of 250 patients (168 men and 132 women, 18-69 years of age) was 
randomly divided into five subgroups (each one of 50 subjects: 28 men and 22 
women). The volunteers enrolled in this study had the following values of serum 
cholesterol parameters at baseline: TC, 200-260 mg/dL; HDL-C, 31-45 mg/dL; 
LDL-C, 179-206 mg/dL. Four groups were assigned to consume one apple per day 
among the following: Red Delicious (RD), Granny Smith (GS), Fuji (F), Golden 
Delicious (GD). The fifth group was asked to consume two Annurca apples per 
day, since the weight of this cultivar is on average half that of the commercial 
varieties in this study. 
 
 
 
 
 
69 
 
5.1.5 Study outcomes and data collection 
Primary and secondary efficacy outcomes 
Primary endpoints measured were the variations in TC, HDL-C and LDL-C levels, 
while key secondary outcomes collected during clinic visits were measurements of 
blood pressure and heart rate, and evaluation of BMI.  
All raw patient ratings were evaluated in a blinded manner at the site of the 
principal investigator. The decision process was performed according to a 
consensus document before unblinding in order to define conclusive primary and 
secondary efficacy data from a clinical perspective.  
Safety 
Although no specific toxicity studies have been performed herein, mutagenicity 
tests and acute/subacute toxicity studies have long since demonstrated the safety of 
polyphenol content of apples, both in mice and humans. Nevertheless, we assessed 
safety from reports of adverse events as well as laboratory parameters concerning 
hepatic and renal function, vital signs (blood pressure, pulse, height, weight and 
BMI), and physical or neurological examinations. Safety was assessed over the 
entire treatment period at weeks 0, 4, 8, 12 and 16, including adverse events 
occurring in the first 3 weeks after cessation of treatments.  
 
5.1.6 Statistics 
Methodology 
During the trial, it became apparent that dropouts and incomplete diary 
documentation created missing data that could not be adequately handled by the 
intended robust comparison. To deal with the missing data structure, we used a 
negative binomial, generalised linear mixed-effects model (NB GLMM) that not 
only yields unbiased parameter estimates when missing observations are missing at 
random (MAR) (Little et al., 2002), but also provides reasonably stable results even 
when the assumption of MAR is violated (Molenberghs et al., 2004; O‟Kelly et al., 
2014). Patients who did not provide any diary data (leading to zero evaluable days) 
were excluded from the MAR-based primary efficacy analysis, according to an “all 
observed data approach” as proposed by White and colleagues (White et al., 2012). 
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This approach is statistically efficient without using multiple imputation techniques 
(Carpenter et al., 2007). Data retrieved after withdrawal of randomised study 
treatment were also included in the analysis. 
Unless otherwise stated, all the experimental results were expressed as mean ± 
standard deviation (SD) of at least five replications. Statistical analysis of data was 
performed using Student‟s t-test or two-way analysis of variance (ANOVA) 
followed by the Tukey-Kramer multiple comparison test to evaluate significant 
differences between a pair of means. The statistic heterogeneity was assessed using 
Cochran‟s test (P < 0.1). The I2 statistic was also calculated and I2 > 50% was 
considered as significant heterogeneity across studies. A random-effects model was 
used if significant heterogeneity was shown among the trials. Otherwise, results 
were obtained from a fixed-effects model. Percentage change in mean and SD 
values were excluded when extracting SD values for an outcome. SD values were 
calculated from standard errors, 95% CIs, P-values, or t if they were not available 
directly. Previously defined subgroup analyses were performed to examine the 
possible sources of heterogeneity within these studies and included health status, 
study design, type of intervention, duration and Jadad score. Treatment effects were 
analysed using PROC MIXED with treatment (placebo, fresh apples) and period as 
fixed factors, subject as random factors and baseline measurements as covariates, 
and defined as weighted mean difference and 95% CIs calculated for net changes in 
serum cholesterol and blood pressure values. Data that could not meet the criteria of 
variance homogeneity (Levene‟s test) and normal distribution (determined by 
residual plot examination and Shapiro-Wilk test) even after log transformation were 
analysed using a nonparametric test (Friedman). The level of significance (α-value) 
was 95% in all cases (P < 0.05).  
Analysis sets 
The full analysis set population included all patients randomised and who did not 
fail to satisfy a major entry criterion. We excluded patients who provided neither 
primary nor secondary efficacy data from efficacy analyses. The per protocol set 
consisted of all patients who did not substantially deviate from the protocol; they 
had two characteristics. Firstly, this group included patients for whom no major 
protocol violations were detected (e.g. poor compliance, errors in treatment 
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assignment). Secondly, they were on treatment for at least 50 days, counting from 
day of first intake (completion of a certain pre-specified minimal exposure to the 
treatment regimen). Hence patients who prematurely discontinued the study or 
treatment before day 44 were excluded from the per protocol sample. 
Determination of sample size 
Pilot data from an interventional study supported the assumption that the 
probability to achieve a better result on apple extract than placebo is 0.71 
(Nagasako-Akazome et al., 2005). Hence a sample size of 21 patients in each group 
would have 77% power to detect the difference between two groups using a two-
sided Mann-Whitney U test at a 5% significance level. Assuming a dropout rate of 
about 37%, a minimum of 34 patients in each treatment group had to be enrolled.  
Patient involvement 
No patients were involved in setting the research question or the outcome measures, 
nor they were involved in developing plans for participant recruitment, or the 
design and implementation of the study. There are no plans to explicitly involve 
patients in dissemination. Final results will be sent to all participating sites. 
 
5.2 Results and discussion 
In order to verify that the in vitro properties of Annurca apple were also maintained 
in vivo, a 16-week clinical trial was performed. Specifically, it aimed to understand 
if the cholesterol-lowering effect after Annurca daily consumption was really 
superior to that of other cultivars regularly consumed (Tenore et al., 2016). 
Differently from in vitro studies, it was decided to use in in vivo studies Granny 
Smith cultivar instead of Pink Lady apple, for various reasons. Firstly, Granny 
Smith and Pink Lady apples possess similar polyphenolic profiles, so equivalent in 
vivo effects could be reasonably supposed. Secondly, Granny Smith apple is the 
only cultivar currently employed for the formulation of a nutraceutical product 
(Applephenon
®
) of which clinical study results, regarding the effects on plasma 
cholesterol levels, are available (Nagasako-Akazome et al., 2005). Last, but not 
least, Granny Smith apple is more widespread and commercially interesting than 
Pink Lady. 
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5.2.1 Enrolment and subject attrition 
Patient enrolment occurred in November 2015. A total of 340 patients were 
screened for eligibility; 90 patients (26.5%) did not pass the screening stage, while 
the remaining 250 patients were randomised. The exclusion of 90 patients was due 
to various factors. The most common cause was that patients did not have the 
inclusion criteria regarding values of serum cholesterol parameters at baseline (n = 
38), followed by general refusal to participate for no specific reason (n = 14) or for 
concerns about the protocol, especially fear of placebo (n = 4). The other patients 
were excluded because they had one or more exclusion criteria (n = 34).  
Successively, the 250 patients were assigned to the group consuming apples. They 
were divided into five subgroups, each one formed by 50 patients, on the basis of 
the different apple cultivars chosen for the study. All the patients underwent a 
placebo period for the first 4 weeks, during which they did not consume any kind of 
apple in the habitual diet; then, they started the treatment period of 8 weeks, during 
which they were asked to consume a different apple cultivar one per day (Red 
Delicious, Granny Smith, Fuji or Golden Delicious) or two per day (Annurca); 
finally, there was a follow-up period during the last 4 weeks, and patients were 
asked to stop the consumption of apple fruits. No patient dropped out from study 
participation before allocation to treatment. 
The flow of participants through the trials and the completeness of diary 
information over the entire treatment period are shown in Figure 27. It follows the 
CONSORT PRO reporting guideline (Calvert et al., 2013) and reveals that, during 
the assessment period, the following percentages of patients for each group and 
subgroup provided data for the primary endpoint: RD, 88.6% (39 of 44 patients); 
GS, 88.9% (40 of 45 patients); F, 89.4% (42 of 47 patients); GD, 86.7% (39 of 45 
patients); Annurca, 86.7% (39 of 45 patients). In each group, a few patients did not 
hand in any diaries, not giving any specific reason. However, completeness of the 
patient diaries did not differ between the treatment groups. 
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Figure 27: Study flow chart, according to the consolidated standards of reporting trials (CONSORT). The diagram shows enrolment and primary efficacy endpoints 
based on patient diaries, from pre-screening to data collection, and the extent of exclusions, loss to follow-up and completeness of diary documentation available across 
the entire trial period. RD, Red Delicious apple; GS, Granny Smith apple; F, Fuji apple; GD, Golden Delicious apple; Ann, Annurca apple; FAS, full analysis set.
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5.2.2 Participants’ baseline characteristics 
The demographic and clinical characteristics assessed at the baseline visit of all 250 
patients randomised are reported in Table 5. The subjects involved were white and 
ranged from 18 to 83 years old; about half of the randomised subjects were female. 
The five groups were well balanced for demographics and clinical parameters. 
Table 5: Baseline characteristics of intention-to-treat sample according to study 
treatment. 
Placebo 
Characteristics Ann (n=50) RD (n=50) GS (n=50) F (n=50) GD (n=50) 
Demographics      
Age (years) 42.4 ± 10.6 41.8 ± 10.8 43.8 ± 10.5 44.8 ± 11.2 42.7 ±11.2 
Male sex ((No (%)) 28 (56%) 26 (52%) 27 (54%) 25 (50%) 26 (52%) 
White ethnicity ((No (%)) 50 (100%) 50 (100%) 50 (100%) 50 (100%) 50 (100%) 
Clinical parameters      
TC (mg/dL) 240.2 ± 11.5 236.3 ± 12.4 239.1 ± 13.4 233.5 ± 12.6 236.1 ± 13.8 
LDL-C (mg/dL) 187.9 ± 12.1 185.2 ± 11.9 191.0 ± 11.3 184.1 ± 12.3 187.8 ± 13.1 
HDL-C (mg/dL) 39.9 ± 6.8 36.2 ± 7.7 36.8 ± 6.1 36.3 ± 7.2 32.9 ± 7.3 
Glucose (mg/dL) 111.2 ± 9.2 88.7 ± 2.2 99.5 ± 8.1 91.4 ± 9.4 100.1 ± 7.3 
Triglycerides (mg/dL) 87.1 ± 9.2 102.8 ± 12.1 93.6 ± 11.8 92.4 ± 10.2 102.3 ± 12.1 
Treatment 
Characteristics Ann (n=45) RD (n=44) GS (n=45) F (n=47) GD (n=45) 
Demographics      
Age (years) 43.5 ± 10.2 42.1 ± 11.1 44.2 ± 10.6 45.5 ± 10.7 43.8 ± 12.2 
Male sex ((No (%)) 25 (55.5%) 23 (52.3%) 24 (53.3%) 23 (48.9%) 23 (51.1%) 
White ethnicity ((No (%)) 45 (100%) 44 (100%) 45 (100%) 47 (100%) 45 (100%) 
Clinical parameters      
TC (mg/dL) 239.1 ± 11.9 235.9 ± 13.7 237.6 ± 14.3 235.5 ± 13.3 238.4 ± 15.3 
LDL-C (mg/dL) 189.6 ± 11.7 183.7 ± 12.3 189.1 ± 11.6 185.7 ± 11.1 189.1 ± 11.6 
HDL-C (mg/dL) 38.5 ± 7.2 37.9 ± 8.1 35.4 ± 6.7 36.7 ± 7.5 34.2 ± 6.9 
Glucose (mg/dL) 109.3 ± 8.9 89.5 ± 2.7 98.6 ± 8.5 90.5 ± 10.0 101.2 ± 9.3 
Triglycerides (mg/dL) 85.4 ± 8.3 101.5 ± 16.8 95.5 ± 9.0 90.3 ± 10.4 100.5 ± 11.8 
Values are means ± SD.  
Ann: Annurca apple; RD: Red Delicious apple; GS: Granny Smith apple; F: Fuji apple; 
GD: Golden Delicious apple.  
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5.2.3 Primary efficacy outcome measures 
Firstly, patients enrolled underwent 4 weeks of placebo treatment, consisting in the 
habitual diet without apples. At the end of placebo period no significant variation of 
plasma TC, LDL-C and HDL-C levels compared to the baseline values was 
registered, as shown in Table 5.  
Then, the four groups of patients were asked to consume for 8 weeks one apple per 
day among the following: Red Delicious, Granny Smith, Fuji and Golden 
Delicious. The fifth group had to consume two Annurca apples per day, since the 
weight of this cultivar is on average half that of the other commercial cultivars. The 
administration of apples led, in all groups, to a statistically significant variation of 
plasma TC, LDL-C and HDL-C levels. All the results are reported in Table 6.   
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Table 6: Effects of apple samples on plasma cholesterol, glucose and triglyceride metabolism. 
  Ann Δ (%) RD Δ (%) GS Δ (%) F Δ (%) GD Δ (%) 
TC 
(mg/dL) 
t 0 239.1 ± 11.9  235.9 ± 3.7  237.6 ± 4.3  235.5 ± 3.3  238.4 ± 5.3  
t 30 219.2 ± 12.8 -8.3 228.5 ± 4.2 -3.1 227.2 ± 3.5 -4.4 230.8 ± 4.1 -2.0 235.3 ± 1.9 -1.3 
t 60 218.9 ± 12.1 -8.4 229.0 ± 3.6 -2.9 226.9 ± 3.8 -4.5 230.1 ± 3.4 -2.3 235.8 ± 2.0 -1.1 
LDL-C 
(mg/dL) 
t 0 189.6 ± 11.7  183.7 ± 2.3  189.1 ± 1.6  185.7 ± 1.1  189.1 ± 1.6  
t 30 161.6 ± 10.9 -14.7 171.7 ± 1.3 -6.5 172.4 ± 0.8 -8.8 177.6 ± 1.7 -4.4 184.1 ± 2.0 -2.6 
t 60 161.9 ± 11.2 -14.5 173.1 ± 1.6 -5.8 173.4 ± 1.2 -8.3 176.9 ± 2.1 -4.7 184.1 ± 2.3 -2.6 
HDL-C 
(mg/dL) 
t 0 38.5 ± 7.2  37.9 ± 8.1  35.4 ± 6.7  36.7 ± 7.5  34.2 ± 6.9  
t 30 44.3 ± 7.9 +15.2 39.5 ± 7.5 +4.2 37.6 ± 8.0 +6.2 37.7 ± 6.8 +2.7 34.7 ± 6.4 +1.5 
t 60 43.9 ± 8.1 +14.0 39.9 ± 7.0 +5.3 37.0 ± 8.3 +4.5 38.2 ± 6.0 +4.1 35.1 ± 5.6 +2.6 
Glucose 
(mg/dL) 
t 0 109.3 ± 8.9  89.5 ± 2.7  98.6 ± 8.5  90.5 ± 10.0  101.2 ± 9.3  
t 30 118.3 ± 12.0 +8.2 103.4 ± 10.8 +15.5 100.9 ± 12.4 +2.3 99.4 ± 8.3 +9.8 111.3 ± 10.1 +10.1 
t 60 120.3 ± 13.1 +10.1 101.2 ± 11.6 +13.1 105.4 ± 10.3 +6.9 104.5 ± 10.1 +15.5 109.3 ± 9.8 +8.0 
Triglycerides 
(mg/dL) 
t 0 85.4 ± 15.2  101.5 ± 16.8  95.5 ± 13.0  90.3 ± 18.4  100.5 ± 11.8  
t 30 91.5 ± 16.4 +7.2 111.3 ± 19.3 +9.7 111.2 ± 21.1 +16.5 102.7 ± 16.7 +13.7 107.7 ± 13.4 +7.2 
t 60 90.6 ± 17.3 +6.1 109.9 ± 14.7 +8.3 107.6 ± 15.2 +12.7 100.0 ± 14.2 +10.8 109.8 ± 16.5 +9.3 
Values are means ± SD (n = 5). 
Subjects consumed either one apple/day or two Annurca apples/day for 2 months. 
Results were significantly different at a level of P = 0.001.  
Ann: Annurca; RD: Red Delicious; GS: Granny Smith; F: Fuji; GD: Golden Delicious. 
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All the discussed results refer to the second month of intervention study, but 
actually noteworthy results were obtained already after one month. 
The highest hypocholesterolemic effect was exerted by Annurca apple, which 
decreased TC levels by 8.4% (95% CI: -2.54, P = 0.0095). It was followed by 
Granny Smith and Red Delicious apples, which led to a decrease by 4.5% and 
2.9%, respectively. The lowest efficacy was observed for Fuji and Golden 
Delicious apples, which reduced TC levels by 2.3% and 1.1%, respectively. 
Currently, several human studies have been carried out in order to investigate the 
hypocholesterolemic effects of apples or apple products. These studies concluded 
that dietary intervention with whole fresh apples leads to the most appreciable 
results, whereas no significant effects were registered with other apple products, 
such as juice and whole dried apples. Gormley et al. conducted a study involving 
76 men afflicted by mild hypercholesterolemia. The design considered two 
groups: the intervention group had to eat an average of three apples (Irish Golden 
Delicious) a day and the control group had to eat a maximum of three apples per 
week, both over 4 months. The plasma cholesterol levels of the intervention group 
decreased by 8.1% (Gormley et al., 1977). Other two studies used a design 
consisting of a single intervention with supplementation of two to three apples 
(Red Delicious or Golden Delicious) a day, without using a control group (Sablé-
Amplis et al., 1983; Girault et al., 1988). The study performed by Sablé-Amplis 
and colleagues involved 30 hypercholesterolemic men and women, who had to 
maintain their habitual diet and to add apples as prescribed. In both groups a 
significant decrease in TC levels was observed (by 9 to 12%) after 1 month of 
intervention (Sablé-Amplis et al., 1983). The study performed by Girault et al. did 
not have any inclusion or exclusion criteria and lasted 2 months. This study 
involved 235 men and women, and 109 of these subjects were overweight or 
hypercholesterolemic. Only among this latter group significant results were found, 
since TC levels decreased by 5% (Girault et al., 1988). Ravn-Haren and 
colleagues performed a single-blind, randomised, cross-over human study in order 
to evaluate the effect on plasma cholesterol in 34 healthy men and women, who 
were assigned to consume 550 g of whole apples (Shampion cultivar) per day 
over a period of 4 weeks. A slight decrease (5.6%) in TC levels was found (Ravn-
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Haren et al., 2013). The other available human studies performed using whole 
apples did not show any significant variation of plasma TC levels (Canella et al., 
1963; Mayne et al., 1982; Mahalko et al., 1984). 
The same trend found for TC (Annurca > GS > RD > F > GD) was observed as 
regards LDL-C lowering effects. In fact, on average apple consumption led to a 
significant decrease in plasma LDL-C levels and Annurca apple was about 1.7-
fold more active in reducing the LDL-C (-14.5%, 95% CI: -3.41, P = 0.0019) than 
Granny Smith apple (-8.3%).  
Published human studies reported that dietary intervention with whole fresh 
apples leads to a slight reduction in plasma LDL-C levels, while no significant 
effects were registered with other apple products, such as juice and whole dried 
apples. The above-mentioned human study performed by Girault et al. reported 
that plasma LDL-C levels decreased by 5.5% (Girault et al., 1988). Hyson and 
colleagues evaluated the effect on plasma total cholesterol in 25 healthy men and 
women, who were asked to eat 340 g of whole apples a day, through an unblind, 
randomised, cross-over human study, and they observed a small, but not 
significant, reduction (5%) in plasma LDL-C levels (Hyson et al., 2000). The 
above-mentioned human study performed by Ravn-Haren and colleagues showed 
a decrease in plasma LDL-C levels by 6.7% (Ravn-Haren et al., 2013).  
A similar trend was observed for HDL-C values, too. In fact, Annurca apple 
showed the greatest effect (+14.0%, 95% CI: -1.22, P = 0.0042) compared to 
Granny Smith (+4.5%), Red Delicious (+5.3%), Fuji (+4.1%) and Golden 
Delicious (+2.6%) cultivars. 
Previous human dietary intervention studies with both whole fresh apples and 
apple products reported contrasting results as regards plasma HDL-C levels. The 
above-mentioned studies performed by Gormley et al. and Girault et al., both 
using apples, registered an increase by 12.5% and a decrease by 5.8%, 
respectively, in HDL-C levels (Gormley et al., 1983; Girault et al., 1988). A 
cross-over study considered the administration for 6 weeks of 568 mL of filtered 
apple juice per day to 25 hypercholesterolemic men and showed a significant 
decrease (-9%) in HDL-C plasma levels (Mee et al., 1997). Other studies, 
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involving the administration of either fresh apples or apple products, did not 
report any significant variation of plasma HDL-C levels (Canella et al., 1963; 
Mayne et al., 1982; Sablé-Amplis et al., 1983; Mahalko et al., 1984; Davidson et 
al., 1998; Hyson et al., 2000; Ravn-Haren et al., 2013).  
The molecular mechanism of action that underlies these effects is still to be 
clarified, but, according to the in vitro studies, it can be hypothesised that apple 
procyanidins would play a major role in regulating plasma cholesterol levels. In 
fact, an impressive correlation was found when comparing the in vivo 
hypolipidemic effect of each single apple cultivar with their procyanidin content. 
Annurca had the highest content in procyanidins and showed to be the most 
effective, whereas Fuji and Golden Delicious were the poorest in procyanidin 
amount and were also the least active in affecting cholesterol serum levels.  
However, the daily intake of apples increased significantly plasma glucose and 
triglyceride levels, as reported in Table 6. The major rise in glucose levels 
occurred in patients that consumed Fuji apples (+15.5%, 95% CI: -5.68, P = 
0.0042), whereas the least effective on raising plasma glucose levels was Granny 
Smith apple (+6.9%, 95% CI: -4.21, P = 0.0032). As regards triglyceride levels, 
Granny Smith apple increased their levels by about 12.7% (95% CI: -2.21, P = 
0.0032). All the other apple cultivars affected the triglyceride levels to a lesser 
extent (Fuji, +10.8%, 95% CI: -3.54, P = 0.0036; Golden Delicious, +9.3%, 95% 
CI: -5.13, P = 0.0029; Red Delicious, +8.3%, 95% CI: -5.06, P = 0.0012; 
Annurca, +6.1%, 95% CI: -2.46, P = 0.0027). 
These effects are not surprising, because about 90% of the energy from an apple 
derives from its carbohydrates, mainly sugars, such as fructose and glucose. 
Fructose is lipogenic, since its breakdown products can either enter the Krebs 
cycle or serve as substrates for the formation of mevalonate and triglycerides 
(Dekker et al., 2010).  
 
5.2.4 Safety issue, study strength and limitations 
The safety of polyphenolic content of apples was assessed through mutagenicity 
tests and acute/subacute toxicity studies both in mice and humans, although no 
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specific toxicity studies were performed during this study. Nevertheless, patients 
were periodically monitored in order to assess vital signs, blood pressure and 
electrocardiographic findings and baseline values did not change substantially 
during and at the end of the trial (data not reported).  
The major strengths of this clinical trial reside in the originality of the study and 
in the evaluation of the treatment effects in real-world setting, while the main 
limitations of this study are short-term assessment for the treatment of a chronic 
condition and the choice of treating exclusively white race. 
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CHAPTER 6 
In vivo effects on plasma levels of TC, LDL-C and HDL-C after 
administration of the polyphenolic fraction coming from Annurca 
apple cultivar 
6.1 Materials and methods 
6.1.1 Apple collection 
Annurca (Malus pumila cv Annurca) apple fruits (each weighing about 100 g) 
were collected in Valle di Maddaloni (Caserta, Italy) in October when fruits had 
just been harvested (green peel). The fruits were reddened, following the typical 
treatment (Lo Scalzo et al., 2001) for about 30 days, and then analysed. Four other 
apple varieties (each weighing about 200 g) analysed in this study, Red Delicious 
(RD) (Malus pumila Miller cv Red Delicious), Granny Smith (GS) (Malus pumila 
Miller cv Granny Smith), Fuji (F) (Malus pumila Miller cv Fuji) and Golden 
Delicious (GD) (Malus pumila Miller cv Golden Delicious), were purchased from 
a local supermarket. 
 
6.1.2 Preparation of apple extracts 
Lyophilised apples (10 g) were treated with 100 mL of a methanol/water mixture 
(80:20, v/v) acidified with 0.5% formic acid for 24 h at 4 °C in order to extract 
phenolic compounds. After centrifugation, the supernatant was slowly filtered and 
purified through an Amberlite XAD-2 column packed as follows: 10 g of resin 
(pore size 9 nm; particle size 0.3-1.2 mm; Supelco, Bellefonte, PA) was soaked in 
methanol, stirred for 10 min and then packed into a glass column (10 x 2 cm). The 
column was washed with 100 mL of acidified water (pH 2) and 50 mL of 
deionised water in order to remove sugar and other polar compounds. The 
adsorbed phenolic compounds were extracted from the resin by elution with 100 
mL of methanol, which was evaporated by flushing with nitrogen. The 
polyphenolic extracts were stored at -80 °C until analysis.  
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6.1.3 HPLC-DAD/ESI-MS
n 
analysis 
HPLC separation and quantification of phenolic compounds in apple extracts were 
performed according to previous studies with some modifications (Mari et al., 
2010). The identification of phenolic compounds was possible by recording 
chromatograms at different wavelengths, 280 nm for flavonols, procyanidins, 
dihydrochalcones and hydroxycinnamic acids, and 500 nm for anthocyanins and 
by comparing spectra and retention times with those of commercial standards and 
with those reported in previous works (Mari et al., 2010). Elution conditions 
consisted in 2% acetic acid (solvent A) and 0.5% acetic acid in acetonitrile and 
water (50:50, v/v) (solvent B) gradient at a flow rate of 1.0 mL/min. The column 
selected was a Hypersil BDS C18 column (250 mm x 4.6 mm, 5 µm) (Thermo, 
Bellefonte, PA). Analyses were run on a Finnigan HPLC system (Thermo 
Electron Corporation, San Jose, CA) provided with photodiode array detector 
(DAD). The gradient conditions were: 0-5 min, 10% B; 55 min, 55% B; 65 min, 
95% B, followed by 5 min of maintenance. The identity of phenolic acids and 
flavonoids was confirmed with LC-ESI/MS/MS experiments and data were 
compared with those of commercial standards and with those reported in previous 
works (Mari et al., 2010). The same chromatographic conditions were applied to a 
HP1100 HPLC system (Agilent, Palo Alto, CA) coupled to a PE-Sciex API-2000 
triple-quadrupole mass spectrometer (AB Sciex, Warrington, UK) equipped with 
a Turbospray (TSI) source. Individual phenols were separated on a Hypersil BDS 
C18 column (250 mm x 2.1 mm, 5 µm) (Thermo Electron, Bellefonte, PA) at a 
flow rate of 200 µL/min. Mass spectra were recorded from m/z = 50 to 1500, in 
both negative and positive ionisation mode. For negative ion mode, the capillary 
voltage was set at -13 V, the spray voltage was at 4.5 kV and the tube lens offset 
was at -15 V, while in positive ion mode, the capillary voltage was set at 13 V, the 
spray voltage was at 5 kV and the tube lens offset was at -35 V. The capillary 
temperature was 275 °C. Data were acquired in MS, MS/MS and MS
n 
scanning 
modes.  
 
 
 
 
 
 
83 
 
6.1.4 Cell cultures and in vitro experiments 
Human hepatocellular liver carcinoma cells (HepG2, HB-8065) were obtained 
from American Type Culture Collection. Monolayers of cells were grown in T75 
flasks and maintained in DMEM (Dulbecco‟s Modified Eagle‟s Medium) (Sigma 
Chemical Co., St. Louis, MO) supplemented with 10% (v/v) fetal bovine serum 
(FBS), 1% antibiotic/antimycotic solution (Gibco-Invitrogen, Mount Waverley, 
Australia), 0.375% NaHCO3 and 20 mmol/L HEPES, pH 7.4, and incubated at 37 
°C in a humidified atmosphere of 5% CO2 in air. The cells were dispersed with 
trypsin-EDTA (0.05% trypsin and 0.02% EDTA) and plated on the bottom of a 
transparent black 96-well plate in a 200 µL growth medium at a density of 1.0 x 
10
5 
cells/mL. Assays were performed by incubating the culture with 1 µg/mL of 
apple polyphenolic extract for 72 h.  
To determine inhibition of cholesterol uptake, cells were incubated in an F-12 
medium containing 10 nmol/L [1,2-
3
H] cholesterol (PerkinElmer Pty Ltd., 
Melbourne, Australia). The cells were washed twice in F-12 to remove unbound 
[
3
H] cholesterol, and 0.5 mL of 0.1% sodium dodecyl sulphate (SDS) was added 
to each well to solubilise the cells. Three milliliters of Ultima Gold scintillant was 
added, and the radioactivity of the solubilised cells was determined using Wallac 
1410 liquid scintillation counter (Pharmacia, Turku, Finland). For cholesterol 
efflux experiments, cells were washed in F-12 and incubated for 45 min in F-12 
containing 20 nmol/L [
3
H] cholesterol to “load” the cells with cholesterol. Cells 
were then washed twice in F-12 and then incubated (for up to 100 min) containing 
the test samples as shown in the figure legend to determine cholesterol efflux. As 
a positive control, 1% methyl-β-cyclodextrin (MβCD) was used to acutely deplete 
cellular cholesterol. Cells were washed twice in F-12, supernatant was removed, 
and then 0.5 mL of 0.1% SDS was added to solubilise the cells for β counting as 
above.  
The effect of apple polyphenolic extracts on HepG2 LDL receptor binding 
activity was indirectly evaluated by measuring the LDL concentration in the cell 
medium. HepG2 cells were grown in 12-well culture plates, followed by washing 
in PBS and incubation for 24 h in DMEM serum-free media. The cells were then 
washed in PBS and incubated for a further 6 h in DMEM serum-free media 
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containing fluorescent-labeled Dil-LDL (10 mg/L, Biomedical Technologies, 
Stoughton, MA). The fluorescence of the cell medium was measured at 514 nm 
(excitation) and 550 nm (emission) wavelengths by using a LS50B luminescence 
spectrophotometer (PerkinElmer, Waltham, MA).  
The concentration of Apolipoprotein A1 (ApoA1), the main constituting protein 
of nascent discoidal HDL particles, was quantified in the cell culture media in 96-
well plates using an enzyme-linked immunosorbent assay (E90519Hu 96 test kit; 
Gentaur Molecular Products Kampenhout, Belgium), according to the 
manufacturer‟s instructions. 
  
6.1.5 Annurca supplement (AMS) preparation 
The Annurca apple supplement used in this study consisted of gastric-resistant 
capsules containing Annurca apple polyphenolic extract (400 mg/cps) and 
maltodextrin (100 mg). The extract was encapsulated in gastric-resistant capsules 
due to the previous knowledge of salivary and gastric digestion of some 
polyphenolic components. The product was formulated by the Department of 
Pharmacy, University of Naples “Federico II” (Naples, Italy), and registered with 
the name of AppleMetS
TM 
(AMS). Large-scale production of AMS has been 
accomplished by MB-Med Company (Turin, Italy). Apples have been extracted 
with pure ethanol, and the obtained extract solution has been kept at -20 °C for 24 
h in order to allow sugar elimination. After centrifugation, the extract has been 
spray-dried, obtaining a fine powder, which has been used to formulate gastric-
resistant capsules.  
  
6.1.6 Study population and protocol 
The study is listed on the ISRCTN registry with ID ISRCTN15653394. Study 
participants were recruited by the Samnium Medical Cooperative (Benevento, 
Italy). Patients were enrolled in November 2015. Patients aged 18-83 years were 
eligible for enrolment if they had the following values of serum cholesterol 
parameters at baseline: total cholesterol (TC), 200-260 mg/dL; high-density 
lipoprotein cholesterol (HDL-C), 30-45 mg/dL; low-density lipoprotein 
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cholesterol (LDL-C), 189-206 mg/dL. The subjects were asked to keep their 
dietary habits unchanged throughout the entire study.  
Exclusion criteria were: smoking, obesity (body mass index - BMI - > 30 kg/m
2
), 
diabetes, hepatic disease, renal disease, heart disease, family history of chronic 
diseases, drug therapy or supplement intake for hypercholesterolemia, drug 
therapy or supplement intake containing apple polyphenols, heavy physical 
exercise (> 10 h/week), pregnant women, women suspected of being pregnant, 
women who hoped to become pregnant, breastfeeding women, birch pollen 
allergy, use of vitamin/mineral supplements 2 weeks prior to entry into the study 
and donation of blood less than 3 months before the study. 
The subjects received oral and written information concerning the study before 
they gave their written consent. Protocol, letter of intent of volunteers and 
synoptic document about the study were submitted to the Scientific Ethics 
Committee of AO Rummo Hospital (Benevento, Italy). The study was approved 
by the committee (protocol 14303), and carried out in accordance with the 
Helsinki declaration of 1964 (as revised in 2000). The subjects were asked to 
make records in an intake-checking table for the intervention study and side 
effects in daily reports. The study was a monocentric, double-blind, placebo-
controlled trial conducted at the Samnium Medical Cooperative (Benevento, 
Italy).  
The study duration was 16 weeks: the group underwent 4 weeks of placebo 
treatment, consisting in the administration of identically appearing capsules 
containing only maltodextrin, followed by 8 weeks of nutraceutical treatment, and 
4 weeks of follow-up. Both the examinations and the study treatment were 
performed in an outpatient setting. Clinic visits and blood sampling were 
performed after 12 h of fasting at weeks 0, 4, 8, 12 and 16. Subjects were 
informed not to drink alcohol or perform hard physical activity 48 h prior to blood 
sampling. All blood samples were taken in the morning and immediately after 
measurement of heart rate and blood pressure. Blood samples were collected in 
10-mL EDTA-coated tubes (Becton-Dickinson, Plymouth, UK) and the plasma 
was isolated by centrifugation (20 min, 2200 g, 4 °C). All samples were stored at -
80 °C until analysis. Plasma TC, HDL-C and LDL-C levels were determined 
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using commercially available kits from Diacron International (Grosseto, Italy). 
Analyses were performed on a Diacron International Free Carpe Diem, and intra- 
and inter-day variations were 1.4% and 1.6% for TC, 1.6% and 2.2% for LDL-C 
and 2.0% and 2.3% for HDL-C, respectively. In addition to these five meetings, 
six standardised telephone interviews were performed every 14 days starting from 
the first meeting, to verify compliance and increase protocol adherence. These 
interviews reminded patients to complete their intake-checking table for the 
intervention study and to record any treatment discontinuation, or adverse events 
they might have experienced in the meantime (which were also documented 
regularly on the case report forms during each telephone and clinic visit).  
All patients underwent a standardised physical examination, assessment of 
medical history (for up to five years before enrolment), laboratory examination, 
measurement of blood pressure and heart rate, and evaluation of BMI. At each 
clinic visit, patients had to complete three self-administered questionnaires on 
quality of life aspects, and their diaries were checked for data completeness and 
quality of documentation to ensure patient comprehension of the diary items. 
 
6.1.7 Randomisation, concealment and blinding 
A total of 250 eligible patients were assigned to the group in order to receive 
AMS supplement. AMS supplement and placebo were coded with different 
colours and given in random order. The code was not broken until all analyses 
were completed and the results were analysed statistically. If a patient dropped out 
before receiving AMS supplement, he or she was replaced by the next eligible 
patient enrolled at the same centre. The concealed allocation was performed by an 
Internet-based randomisation schedule, stratified by study site. The random 
number list was generated by an investigator with no clinical involvement in the 
trial. Patients, clinicians, core laboratories, and trial staff (data analysts, 
statisticians) were blind to treatment allocation.  
 
6.1.8 Study treatments 
The group of 250 patients (116 men and 134 women, 30-83 years of age) was 
instructed to take two capsules of AMS per day (one capsule at lunch, and one at 
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dinner). The volunteers enrolled in this study had the following values of serum 
cholesterol parameters at baseline: TC, 214-254 mg/dL; HDL-C, 30-43 mg/dL; 
LDL-C, 150-205 mg/dL. AMS product consisted in gastric-resistant capsules, 
each containing 400 mg of Annurca apple polyphenolic extract, and registered 
with the name of AppleMetS
TM 
(AMS). Large-scale production of AMS had been 
accomplished by MB-Med Company (Turin, Italy) with full respect of all the 
good manufacturing practices. Noteworthy, the dose of AMS supplement (800 
mg/day) adopted for the clinical trial was in full accordance with the maximum 
polyphenolic extract daily intake (1000 mg), through food supplements and novel 
foods, indicated by the revised form (January 2015) of the Commission 
Regulation (EC) No. 258/1997, as the safe polyphenolic daily amount compatible 
with a good health state. 
 
6.1.9 Study outcomes and data collection 
Primary and secondary efficacy outcomes 
Primary endpoints measured were the variations of TC, HDL-C and LDL-C 
levels, while key secondary outcomes collected during clinic visits were 
measurements of blood pressure and heart rate, and evaluation of BMI. All raw 
patient ratings were evaluated in a blinded manner at the site of the principal 
investigator. The decision process was performed according to a consensus 
document before unblinding in order to define conclusive primary and secondary 
efficacy data from a clinical perspective.  
Safety 
Although no specific toxicity studies have been performed herein, mutagenicity 
tests and acute/subacute toxicity studies have long since demonstrated the safety 
of polyphenol content of apples both in mice and humans. Specifically, the 
Commission Regulation (EC) No. 258/1997 established 1000 mg as the maximum 
polyphenolic extract daily intake in humans. Accordingly, the AMS dose adopted 
for the trial was of 800 mg/day, an amount reasonably lower than that regarded as 
safe in humans. Nevertheless, we assessed safety from reports of adverse events 
as well as laboratory parameters concerning the hepatic and renal function, vital 
signs (blood pressure, pulse, height, weight and BMI), and physical or 
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neurological examinations. Safety was assessed over the entire treatment period at 
weeks 0, 4, 8, 12 and 16, including adverse events occurring in the first three 
weeks after cessation of treatments. 
 
6.1.10 Statistics 
Methodology 
During the trial, it became apparent that dropouts and incomplete diary 
documentation created missing data that could not be adequately handled by the 
intended robust comparison. To deal with the missing data structure, we used a 
negative binomial, generalised linear mixed effects model (NB GLMM) that not 
only yields unbiased parameter estimates when missing observations are missing 
at random (MAR) (Little et al., 2002), but also provides reasonably stable results 
even when the assumption of MAR is violated (Molenberghs et al., 2004; O‟Kelly 
et al., 2014). Patients who did not provide any diary data (leading to zero 
evaluable days) were excluded from the MAR based primary efficacy analysis, 
according to “an all observed data approach” as proposed by White and 
colleagues (White et al., 2012). This approach is statistically efficient without 
using multiple imputation techniques (Carpenter et al., 2007). Data retrieved after 
withdrawal of randomised study treatment were also included in the analysis. 
Unless otherwise stated, all the experimental results were expressed as mean ± 
standard deviation (SD) of at least five replications. Statistical analysis of data 
was performed by the Student‟s t test or two-way ANOVA followed by the 
Tukey-Kramer multiple comparison test to evaluate significant differences 
between a pair of means. The statistic heterogeneity was assessed by using 
Cochran‟s test (P < 0.1). The I2 statistic was also calculated and I2 > 50% was 
considered as significant heterogeneity across studies. A random-effects model 
was used if significant heterogeneity was shown among the trials. Otherwise, 
results were obtained from a fixed-effects model. Percent change in mean and SD 
values were excluded when extracting SD values for an outcome. SD values were 
calculated from standard errors, 95% CIs, p-values or t if they were not available 
directly. Previously defined subgroup analyses were performed to examine the 
possible sources of heterogeneity within these studies and included health status, 
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study design, type of intervention, duration, total polyphenol dose and Jadad 
score. Treatment effects were analysed using PROC MIXED with treatment 
(placebo, fresh apples, apple supplement) and period as fixed factors, subject as 
random factor and baseline measurements as covariates, and defined as weighted 
mean difference and 95% CIs calculated for net changes in serum cholesterol and 
blood pressure values. Data that could not meet the criteria of variance 
homogeneity (Levene‟s test) and normal distribution (determined by residual plot 
examination and Shapiro-Wilk test) even after log transformation were analysed 
by a nonparametric test (Friedman). The level of significance (α-value) was 95% 
in all cases (P < 0.05). 
Analysis sets 
The full analysis set population included all randomised patients and patients who 
did not fail to satisfy a major entry criterion. We excluded patients who provided 
neither primary nor secondary efficacy data from efficacy analyses. The per 
protocol set consisted of all patients who did not substantially deviate from the 
protocol; they had two characteristics. Firstly, this group included patients for 
whom no major protocol violations were detected (e.g. poor compliance, errors in 
treatment assignment). Secondly, they were on treatment for at least 50 days 
counting from day of first intake (completion of a certain pre-specified minimal 
exposure to the treatment regimen). Hence, patients who prematurely 
discontinued the study or treatment before day 44 were excluded from the per 
protocol sample.  
Determination of sample size 
Pilot data from an interventional study supported the assumption that the 
probability to achieve a better result on apple extract than placebo is 0.71 
(Nagasako-Akazome et al., 2005). Hence, a sample size of 21 patients in each 
group would have 77% power to detect the difference between two groups using a 
two sided Mann-Whitney U test on a 5% significance level. Assuming a dropout 
rate of about 37%, 34 patients in each treatment group had to be enrolled.  
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Patient involvement 
No patients were involved in setting the research question or the outcome 
measures, nor they were involved in developing plans for participant recruitment, 
or the design and implementation of the study. There are no plans to explicitly 
involve patients in dissemination. Final results will be sent to all participating 
sites. 
 
6.2 Results and discussion 
6.2.1 Polyphenolic extracts profiling and in vitro effects on cholesterol 
metabolism 
The incubation of HepG2 cells with polyphenolic extracts coming from different 
apple cultivars (Annurca, Red Delicious, Granny Smith, Fuji and Golden 
Delicious) indicated that Annurca polyphenolic extract was more effective on 
cholesterol metabolism than the other apple polyphenolic extracts, as it increased 
TC levels by 5.5 times (Figure 28A), decreased LDL-C concentrations by 48% 
(Figure 28B) and enhanced ApoA1 levels by 2 times (Figure 28C) in the cell 
medium with respect to control cells. 
 
Figure 28A: Effects of apple polyphenolic extracts on HepG2 cell line cholesterol uptake. Data 
are referred to concentrations in the cell medium and are the means ± SD (n = 3). 
abcdef
Mean values 
with different superscript letters are significantly different by the Tukey-Kramer multiple 
comparison test. Results were significantly different at a level of P = 0.001.  
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Figure 28B: Effects of apple polyphenolic extracts on HepG2 cell line low-density lipoprotein 
(LDL) receptor binding activity. Data are referred to concentrations in the cell medium and are the 
means ± SD (n = 3). 
abcdef
Mean values with different superscript letters are significantly different 
by the Tukey-Kramer multiple comparison test. Results were significantly different at a level of    
P = 0.001. 
 
 
Figure 28C: Effects of apple polyphenolic extracts on HepG2 cell line ApoA1 protein expression. 
Data are referred to concentrations in the cell medium and are the means ± SD (n = 3). 
abcde
Mean 
values with different superscript letters are significantly different by the Tukey-Kramer multiple 
comparison test. Results were significantly different at a level of P = 0.001. 
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and Mass Spectrometry (MS) was used, so the qualitative and quantitative profile 
of whole apple samples was determined. The results are reported in Table 7 and 8.  
Table 7: Antioxidant composition (% ± SD; n = 5) of apple polyphenolic extracts 
and Annurca supplement (AMS) determined by HPLC-DAD-MS analysis. 
 ANN RD GS F GD AMS 
Procyanidins 
62.91 ± 
2.1 
41.47 ± 
1.8 
62.40 ± 
2.2 
58.01 ± 
1.0 
51.70 ± 
0.9 
64.07 ± 
2.5 
Dihydrochalcones 
5.88 ± 
0.4 
16.80 ± 
0.9 
3.98 ± 
0.5 
6.82 ± 
0.08 
5.04 ± 
0.4 
4.06 ± 
0.8 
Flavonols 
29.86 ± 
0.7 
37.72 ± 
1.4 
30.64 ± 
0.6 
31.17 ± 
1.0 
41.51 ± 
1.1 
29.77 ± 
1.7 
Anthocyanins 
1.50 ± 
0.08 
2.93 ± 
0.2 
1.90 ± 
0.04 
1.19 ± 
0.03 
0.09 ± 
0.0 
1.42 ± 
0.1 
Data are the means ± SD (n = 3).  
Results were significantly different at a level of P = 0.001.  
ANN: Annurca; RD: Red Delicious; GS: Granny Smith; F: Fuji; GD: Golden Delicious. 
The analyses showed that the polyphenolic profile of Annurca was similar to that 
found in other apple cultivars and consisted of dihydrochalcones (5.88%), 
flavonols (29.86%), anthocyanins (1.5%), but it was particularly rich in 
procyanidins (62.91%). Particularly, Annurca and Granny Smith polyphenolic 
extracts were very similar, with an almost identical content in procyanidins 
(62.91% and 62.40%, respectively) (Table 7).  
Table 8: Polyphenolic composition of apple samples determined by HPLC-DAD-
MS analysis. 
 Annurca RD GS F GD 
Total polyphenols 135.31 ± 2.1 101.57 ± 1.7 95.87 ± 2.3 45.27 ± 1.1 32.13 ± 1.2 
Procyanidins 85.09 ± 2.2 42.12 ± 1.5 59.82 ± 0.6 26.26 ± 0.2 16.61 ± 0.8 
Dihydrochalcones 7.82 ± 0.5 17.06 ± 0.9 3.82 ± 0.2 3.09 ± 0.06 1.62 ± 0.08 
Flavonols 40.41 ± 0.6 38.31 ± 1.0 29.38 ± 0.4 14.11 ± 0.8 13.34 ± 0.5 
Anthocyanins 2.03 ± 0.09 2.98 ± 0.1 1.82 ± 0.03 0.54 ± 0.01 0.03 ± 0.00 
Data are expressed as mg/100 g FW and are the means ± SD (n = 3).  
Results were significantly different at a level of P = 0.001.  
RD: Red Delicious; GS: Granny Smith; F: Fuji; GD: Golden Delicious. 
However, Annurca apple cultivar showed the highest total amount of polyphenols 
(135.31 mg/100 g FW), and, in particular, procyanidin levels were greater (from 
1.4 to 5.1 times) than those found in the other apple cultivars (Table 8). 
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Table 9 indicates that procyanidins occurred in apples as a mix of dimers (mainly, 
procyanidin B2), trimers (e.g. procyanidin C1), tetramers, pentamers or higher 
molecular weight oligomers. All apple cultivars exhibited a comparable 
oligomeric procyanidin profile, with the exception of Annurca, which resulted 
richer in dimers than the other cultivars tested herein. 
Table 9: Composition (% ± SD; n = 5) of apple and Annurca supplement (AMS) 
procyanidin fractions determined by HPLC-DAD-MS analysis. 
 ANN RD GS F GD AMS 
Dimers 
(n = 2) 
26.91 ± 
1.1 
7.24 ± 
0.7 
11.13 ± 
0.6 
10.06 ± 
0.7 
8.70 ± 
0.7 
28.50 ± 
0.9 
Trimers 
(n = 3) 
9.06 ± 
0.8 
8.02 ± 
0.9 
12.34 ± 
1.2 
11.14 ± 
1.0 
8.64 ± 
0.9 
8.95 ± 
1.2 
Tetramers 
(n = 4) 
3.84 ± 
0.5 
5.68 ± 
0.4 
8.75 ± 
0.5 
7.88 ± 
0.6 
6.12 ± 
0.5 
3.77 ± 
0.8 
Pentamers 
(n = 5) 
5.25 ± 
0.2 
3.84 ± 
0.2 
5.87 ± 
0.6 
5.34 ± 
0.4 
4.62 ± 
0.2 
5.18 ± 
0.5 
Hexamers 
(n = 6) 
6.62 ± 
0.4 
3.29 ± 
0.3 
4.92 ± 
0.4 
4.44 ± 
0.2 
3.84 ± 
0.3 
6.54 ± 
0.4 
Oligomers 
(7 ≤ n ≤10) 
11.22 ± 
1.8 
13.6 ± 
0.9 
19.38 ± 
1.5 
18.71 ± 
1.4 
16.38 ± 
1.2 
11.13 ± 
1.5 
Total 
procyanidins 
62.91 ± 
2.1 
41.47 ± 
1.8 
62.40 ± 
1.8 
58.01 ± 
1.0 
51.70 ± 
0.9 
64.07 ± 
2.5 
Data are the means ± SD (n = 3).  
Results were significantly different at a level of P = 0.001.  
ANN: Annurca; RD: Red Delicious; GS: Granny Smith; F: Fuji; GD: Golden Delicious. 
Thus, to understand if there was a correlation between the different procyanidin 
profile and the in vitro effects on cholesterol uptake, LDL receptor binding 
activity and ApoA1 protein expression, HepG2 cells were incubated with each 
procyanidin oligomeric form (n = 2, 3, 4, 5 and the mix of 7 ≤ n ≤ 10) at the same 
molar concentrations. The results indicated that dimers (mostly procyanidin B2) 
were the most effective in decreasing LDL-C levels (-60% than control cells) 
(Figure 29A) and in increasing ApoA1 levels (+85.7% than control cells) (Figure 
29B), whereas the mixture of oligomers (7 ≤ n ≤ 10) was the most effective in 
increasing total cholesterol levels (almost 9 times than control cells) (Figure 29C) 
in the cell medium. 
 
 
 
94 
 
 
Figure 29A: HepG2 cell line low-density lipoprotein (LDL) receptor binding activity. Data are 
referred to concentrations in the cell medium and are the means ± SD (n = 3). 
abcdef
Mean values 
with different superscript letters are significantly different by the Tukey-Kramer multiple 
comparison test. Results were significantly different at a level of P = 0.001.  
 
 
Figure 29B: HepG2 cell line ApoA1 protein expression. Data are referred to concentrations in the 
cell medium and are the means ± SD (n = 3). 
abcd
Mean values with different superscript letters are 
significantly different by the Tukey-Kramer multiple comparison test. Results were significantly 
different at a level of P = 0.001.  
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Figure 29C: HepG2 cell line cholesterol uptake. Data are referred to concentrations in the cell 
medium and are the means ± SD (n = 3). 
abcdef
Mean values with different superscript letters are 
significantly different by the Tukey-Kramer multiple comparison test. Results were significantly 
different at a level of P = 0.001. 
Procyanidin B2 is the most abundant component of dimeric fraction in Annurca 
apple. It is a dimer of (-)-epicatechin, a molecule commonly found in green tea 
and cocoa. In a previous work, the treatment of HepG2 cells with green tea 
catechins led to a decrease in cholesterol content in the cell medium (-30%) and to 
the activation of SREBP-1 transcription factor, which determined an up-regulation 
of LDL receptors (Bursill et al., 2006). Another in vitro experiment reported that 
HepG2 cells treated with procyanidin B2 (a dimer) showed an up-regulation of 
SREBP-1 greater than those treated with procyanidin C1 (a trimer), while an 
increase in the expression of SREBP-2 was registered by both B2 treated cells and 
C1 treated cells (Yasuda et al., 2011).  
Thus, the activation of SREBP pathway leads to an induction of LDL receptor 
over-expression, an effect also exploited by the most used hypolipidemic drugs in 
the world, statins. In fact, statins inhibit liver cholesterol biosynthesis, a block 
sensed by the SREBP pathway, which enhances its active form and induces LDL 
receptor over-expression (DeBose-Boyd et al., 2001). Therefore, dimeric 
procyanidins may be considered able to exert a statin-like LDL-lowering effect. 
However, differently from statins, which are not able to rise HDL-C plasma levels 
(< 10%), dimeric procyanidins affect in vitro ApoA1 concentration (+85.7%), 
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which is an important factor for the formation of the nascent discoidal HDL and 
for the activation of LCAT, an enzyme essential for cholesterol esterification and 
HDL maturation (Mei et al., 2015). 
Thus, in order to verify if the in vitro properties of Annurca were maintained in 
vivo, too, capsules containing polyphenolic extract deriving from Annurca apple 
were administered for two months to 250 mildly hypercholesterolemic healthy 
subjects. Specifically, Annurca polyphenolic extract was encapsulated in gastric–
resistant capsules (400 mg/capsule) and registered as AppleMetS
TM
 (AMS). 
Patients enrolled were asked to take two capsules per day, accounting 800 
mg/day, corresponding to six Annurca apples, an amount per day which is 
unlikely to be reached only through diet (Tenore et al., 2017). 
 
6.2.2 Enrolment and subject attrition 
Patient enrolment occurred in November 2015. A total of 352 patients were 
screened for eligibility; 102 patients (29.0%) did not pass the screening stage, 
while the remaining 250 patients were randomised. The exclusion of 102 patients 
was due to various factors. The most common cause was that patients did not have 
the inclusion criteria regarding values of serum cholesterol parameters at baseline 
(n = 41), followed by general refusal to participate for no specific reason (n = 17) 
or for concerns about the protocol, especially fear of placebo (n = 7). The other 
patients were excluded because they had one or more exclusion criteria (n = 37).  
Successively, the 250 patients were assigned to the group assuming the AMS 
product. Firstly, they underwent a placebo period for the first 4 weeks, during 
which they were given identically appearing capsules containing only 
maltodextrin; then, they started the treatment period of 8 weeks; finally, there was 
a follow-up period during the last 4 weeks, and patients were asked to stop the 
administration of AMS. No patient dropped out from study participation before 
allocation to treatment. 
The flow of participants through the trials and the completeness of diary 
information over the entire treatment period are shown in Figure 30. It follows the 
CONSORT PRO reporting guideline (Calvert et al., 2013) and reveals that, during 
the assessment period, the following percentage of patients provided data for the 
 
 
 
97 
 
primary endpoint: AMS, 83.4% (191 of 229 patients). A few patients did not hand 
in any diaries, not giving any specific reason. 
 
Figure 30: Study flowchart, according to the consolidated standards of reporting trials 
(CONSORT). The diagram shows enrolment and primary efficacy endpoints based on patient 
diaries, from pre-screening to data collection, and the extent of exclusions, loss to follow-up, and 
completeness of diary documentation available across the entire trial period. AMS, AppleMetS
TM
; 
FAS, full analysis set. 
 
 
6.2.3 Participants’ baseline characteristics 
The demographic and clinical characteristics assessed at the baseline visit of all 
250 patients randomised are reported in Table 10. The subjects involved were 
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white and they ranged from 18 to 83 years old; about half of the randomised 
subjects were female. 
Table 10: Baseline characteristics of intention-to-treat sample according to study 
treatment. 
Placebo 
Characteristics AMS (n=250) 
Demographics  
Age (years) 34.7 ± 12.4 
Male sex ((No (%)) 116 (46%) 
White ethnicity ((No (%)) 250 (100%) 
Clinical parameters  
TC (mg/dL) 234.9 ± 13.1 
LDL-C (mg/dL) 183.3 ± 11.4 
HDL-C (mg/dL) 36.2 ± 8.5 
Glucose (mg/dL) 108.2 ± 8.4 
Triglycerides (mg/dL) 97.0 ± 9.3 
Treatment 
Characteristics AMS (n=229) 
Demographics  
Age (years) 36.1 ± 13.8 
Male sex ((No (%)) 105 (45.8%) 
White ethnicity ((No (%)) 229 (100%) 
Clinical parameters  
TC (mg/dL) 233.6 ± 13.7 
LDL-C (mg/dL) 181.3 ± 12.3 
HDL-C (mg/dL) 38.0 ± 8.1 
Glucose (mg/dL) 110.3 ± 9.9 
Triglycerides (mg/dL) 95.1 ± 8.2 
Values are means ±SD. 
AMS: AppleMetS
TM
. 
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6.2.4 Primary efficacy outcome measures 
At the end of placebo period no significant variation of plasma TC, LDL-C and 
HDL-C levels compared to the baseline values was registered, as shown in Table 
10.  
All the discussed results refer to the second month of intervention study, but 
actually noteworthy results were obtained already after one month. After 
treatment with AppleMetS
TM 
supplement, the patients showed a reduction in TC 
and LDL-C levels by 24.9% (95% CI: -5.36, P = 0.0011) and 37.5% (95% CI: -
4.07, P = 0.0021), respectively, and an increase in HDL-C levels by 49.2% (95% 
CI: -2.14, P = 0.0030). Patients who assumed AMS did not show any variation of 
glucose (CI: -0.64, P = 0.0022) or triglyceride (CI: -0.93, P = 0.0048) levels. All 
the results are reported in Table 11.  
Table 11: Effects of Annurca supplement (AMS) on plasma cholesterol, glucose 
and triglyceride metabolism. 
  AMS Δ (%) 
TC 
(mg/dL) 
t 0 233.6 ± 13.7  
t 30 176.1 ± 14.2 -24.6 
t 60 175.4 ± 13.6 -24.9 
LDL-C 
(mg/dL) 
t 0 181.3 ± 12.3  
t 30 112.7 ± 11.3 -37.8 
t 60 113.4 ± 11.6 -37.5 
HDL-C 
(mg/dL) 
t 0 38.0 ± 8.1  
t 30 56.8 ± 7.5 +49.4 
t 60 56.8 ± 7.0 +49.2 
Glucose 
(mg/dL) 
t 0 110.3 ± 9.9  
t 30 109.3 ± 10.2 -0.9 
t 60 110.8 ± 11.1 +0.4 
Triglycerides 
(mg/dL) 
t 0 95.1 ± 14.2  
t 30 96.2 ± 14.4 +1.1 
t 60 95.9 ± 13.3 +0.8 
Subjects were administered with 2 AMS capsules/day for 2 months.  
Values are means ± SD (n = 5).  
Results were significantly different at a level of P = 0.001. 
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Of outmost importance is the impact on HDL-C, since very few natural or 
pharmaceutical substances are able to enhance HDL-C levels. Currently, a number 
of HDL-targeted therapies are emerging and consist of ApoA1 mimetics, 
reconstituted HDL, and CETP (cholesteryl ester transfer protein) inhibitors. 
However, ApoA1 mimetics and reconstituted HDL are able to increase only 
temporarily HDL-C levels, whereas the most potent CETP inhibitor, torcetrapib, 
increases HDL-C levels by up to 106%, but is associated with high mortality 
(Linsel-Nitschke et al., 2005; Kingwell et al., 2014).  
Differently from an apple-rich diet, which could increase blood glucose and 
triglyceride levels, since the fructose contained is lipogenic (Dekker et al., 2010), 
AMS did not have any effect on these parameters. 
A nutraceutical product or a natural remedy may be regarded as significantly 
effective if it is capable of determining a 20% variation of each plasma value of 
TC, LDL-C and HDL-C. Particularly, AMS supplement made possible to 50%, 
75.6% and 85.6%, respectively, of the enrolled subjects to reach these endpoints, 
as shown in Figure 31, 32 and 33, respectively.  
 
Figure 31: Effects of Annurca supplement (AMS) on plasma total cholesterol (TC). Subjects were 
administered with 2 AMS capsules/day for 2 months. Values are means ± SD (n = 5). Results were 
significantly different at a level of P = 0.001. 
 
-65
-60
-55
-50
-45
-40
-35
-30
-25
-20
-15
-10
-5
0
5
10
15
20
Δ
%
 T
C
patients (n = 250)
-24.9%
 
 
 
101 
 
 
Figure 32: Effects of Annurca supplement (AMS) on plasma LDL-C. Subjects were administered 
with 2 AMS capsules/day for 2 months. Values are means ± SD (n = 5). Results were significantly 
different at a level of P = 0.001. 
 
Figure 33: Effects of Annurca supplement (AMS) on plasma HDL-C. Subjects were administered 
with 2 AMS capsules/day for 2 months. Values are means ± SD (n = 5). Results were significantly 
different at a level of P = 0.001. 
Moreover, considering that plasma levels of TC, LDL-C and HDL-C good for 
health are 200, 140 and 50 mg/dL, respectively, AMS supplement made possible 
to 87%, 70.6% and 68.4% of the enrolled subjects to reach the respective 
endpoints. 
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Thus, if the only dietary intervention is not enough for an effective primary 
prevention of cardiovascular diseases, the daily administration of a nutraceutical 
formulation, which provides for the polyphenolic content of six Annurca apples a 
day, may be regarded as a significant therapeutic tool. In particular, the ratio 
LDL-C/HDL-C in the plasma samples of subjects treated with AMS decreased 
from 6.26 to 2.30, and it was correlated to a substantial reduction of the 
cardiovascular risk. The ratio between LDL-C and HDL-C levels is established to 
maximum levels of 3.0-3.5 (women-men) and 2.5-3.0 (women-men) for the 
primary and secondary prevention, respectively (Millán et al., 2009). 
Finally, gender, total cholesterol baseline and age were evaluated in order to 
understand if these variables could affect the efficacy of AMS supplement. The 
results are reported in Table 12. 
The analysis of men and women subgroups revealed that there were not major 
differences as regards TC (men = 95% CI: -0.85, P = 0.0016; women = 95% CI: -
0.63, P = 0.0013), LDL-C (men = 95% CI: -0.74, P = 0.0024; women = 95% CI: -
0.84, P = 0.0036) and HDL-C (men = 95% CI: -0.91, P = 0.0012; women = 95% 
CI: -0.74, P = 0.0022) variations (Table 12). 
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Table 12: Effects of Annurca supplement (AMS) on plasma cholesterol, glucose 
and triglyceride metabolism in subgroups men and women. 
  Men Δ (%) Women Δ (%) 
TC 
(mg/dL) 
t 0 234.2 ± 12.1  233.0 ± 12.3  
t 30 175.4 ± 14.3 -25.2 177.4 ± 13.1 -23.7 
t 60 175.6 ± 12.5 -25.1 176.8 ± 11.9 -24.1 
LDL-C 
(mg/dL) 
t 0 180.5 ± 11.3  181.7 ± 12.9  
t 30 110.5 ± 14.0 -38.7 114.5 ± 10.2 -37.0 
t 60 112.7 ± 10.8 -37.6 113.9 ± 9.8 -37.4 
HDL-C 
(mg/dL) 
t 0 38.6 ± 5.6  37.5 ± 6.4  
t 30 57.9 ± 7.1 +50.0 55.9 ± 3.9 +49.1 
t 60 58.0 ± 4.5 +50.4 55.6 ± 7.2 +48.3 
Glucose 
(mg/dL) 
t 0 111.4 ± 10.7  108.9 ± 11.3  
t 30 110.4 ± 11.3 -1.0 108.1 ± 10.3 -0.7 
t 60 111.7 ± 12.3 +0.3 109.7 ± 11.5 +0.6 
Triglycerides 
(mg/dL) 
t 0 96.3 ± 11.1  94.6 ± 10.4  
t 30 97.4 ± 10.3 +1.2 95.4 ± 12.1 +0.8 
t 60 97.1 ± 11.2 +0.8 94.8 ± 11.0 +0.2 
Subjects were administered with 2 AMS capsules/day for 2 months. 
Value are means ± SD (n = 5). 
Results were significantly different at a level of P = 0.001. 
 
More interesting data emerged when the effectiveness analyses were performed 
on patients divided in subgroups based either on baseline TC values or on age. In 
fact, AMS supplement revealed to be more effective when administered to 
subjects characterised by the highest TC values range (Table 12 TC) (men 214-
229 mg/dL, TC = 95% CI: -2.07, P = 0.0024; LDL-C = 95% CI: -2.94, P = 
0.0040; HDL-C = 95% CI: -4.67, P = 0.0042; men 230-245 mg/dL, TC = 95% CI: 
-5.77, P = 0.0048; LDL-C = 95% CI: -5.22, P = 0.0026; HDL-C = 95% CI: -4.83, 
P = 0.0018; men 246-254 mg/dL, TC = 95% CI: -5.67, P = 0.0038; LDL-C = 95% 
CI: -5.30, P = 0.0034; HDL-C = 95% CI: -3.23, P = 0.0019; women 214-229 
mg/dL, TC = 95% CI: -5.17, P = 0.0014; LDL-C = 95% CI: -5.73, P = 0.0010; 
HDL-C = 95% CI: -4.60, P = 0.0043; women 230-245 mg/dL, TC = 95% CI: -
4.17, P = 0.0032; LDL-C = 95% CI: -5.43, P = 0.0040; HDL-C = 95% CI: -4.23, 
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P = 0.0015; women 246-254 mg/dL, TC = 95% CI: -2.98, P = 0.0028; LDL-C = 
95% CI: -3.43, P = 0.0048; HDL-C = 95% CI: -4.63, P = 0.0014) or to elder 
subjects (Table 12 Age) (men 30-45 years old, TC = 95% CI: -3.07, P = 0.0034; 
LDL-C = 95% CI: -3.49, P = 0.0040; HDL-C = 95% CI: -5.57, P = 0.0036; men 
46-60 years old, TC = 95% CI: -4.38, P = 0.0025; LDL-C = 95% CI: -2.44, P = 
0.0043; HDL-C = 95% CI: -3.44, P = 0.0039; men 61-83 years old, TC = 95% CI: 
-2.77, P = 0.0028; LDL-C = 95% CI: -5.12, P = 0.0026; HDL-C = 95% CI: -4.89, 
P = 0.0030; women 30-45 years old, TC = 95% CI: -4.72, P = 0.0025; LDL-C = 
95% CI: -6.73, P = 0.0011; HDL-C = 95% CI: -3.42, P = 0.0023; women 46-60 
years old, TC = 95% CI: -5.61, P = 0.0037; LDL-C = 95% CI: -5.28, P = 0.0047; 
HDL-C = 95% CI: -4.13, P = 0.0015; women 61-83 years old, TC = 95% CI: -
3.84, P = 0.0024; LDL-C = 95% CI: -3.87, P = 0.0041; HDL-C = 95% CI: -5.63, 
P = 0.0026).  
These data seem to be of outmost importance as the recipients of any 
hypolipidemic treatment are represented mainly by elderly people with an 
unbalanced lipid profile. 
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Table 12 Men TC: Effects of Annurca supplement (AMS) on plasma cholesterol, glucose and triglyceride metabolism in men subgroup 
according to total cholesterol (TC) at baseline. 
  
Men 
(TC:214-229) 
Δ (%) 
Men 
(TC: 230-245) 
Δ (%) 
Men 
(TC: 246-254) 
Δ (%) 
TC 
(mg/dL) 
t 0 222.1 ± 10.2  233.1 ± 12.3  248.0 ± 12.5  
t 30 169.2 ± 12.5 -23.2 176.3 ± 10.4 -25.3 181.2 ± 14.3 -27.1 
t 60 169.7 ± 13.0 -23.0 176.6 ± 11.1 -25.2 181.6 ± 13.1 -27.0 
LDL-C 
(mg/dL) 
t 0 165.3 ± 12.7  180.6 ± 13.1  195.1 ± 12.7  
t 30 104.4 ± 13.2 -36.9 110.6 ± 12.8 -38.9 116.3 ± 13.3 -40.5 
t 60 104.8 ± 12.6 -36.3 112.3 ± 12.8 -37.5 117.6 ± 11.7 -39.3 
HDL-C 
(mg/dL) 
t 0 41.1 ± 3.8  38.9 ± 5.3  35.6 ± 4.2  
t 30 59.6 ± 4.2 +45.0 58.7 ± 6.1 +50.3 55.2 ± 4.4 +55.1 
t 60 60.0 ± 3.7 +46.1 58.7 ± 4.8 +50.5 55.5 ± 6.1 +55.0 
Glucose 
(mg/dL) 
t 0 109.7 ± 11.1  113.4 ± 11.8  111.2 ± 14.1  
t 30 108.9 ± 12.9 -0.9 112.2 ± 12.5 -1.2 110.5 ± 11.8 -0.8 
t 60 109.8 ± 13.6 -0.1 113.7 ± 10.3 +0.3 111.6 ± 12.7 +0.3 
Triglycerides 
(mg/dL) 
t 0 100.2 ± 11.9  90.9 ± 9.3  97.6 ± 11.1  
t 30 101.0 ± 12.4 +0.8 92.6 ± 11.2 +1.7 98.7 ± 11.4 +0.8 
t 60 101.5 ± 11.7 +1.3 91.3 ± 10.6 +0.4 98.2 ± 10.2 +0.6 
Subjects were administered with 2 AMS capsules/day for 2 months. 
Values are means ± SD (n = 5). 
Results were significantly different at a level of P = 0.001. 
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Table 12 Men Age: Effects of Annurca supplement (AMS) on plasma cholesterol, glucose and triglyceride metabolism in men subgroup 
according to age. 
  
Men 
(Age: 30-45) 
Δ (%) 
Men 
(Age: 46-60) 
Δ (%) 
Men 
(Age: 61-83) 
Δ (%) 
TC 
(mg/dL) 
t 0 228.6 ± 11.5  233.6 ± 12.8  240.1 ± 13.1  
t 30 174.4 ± 12.5 -23.9 175.7 ± 13.8 -24.8 176.2 ± 14.1 -26.9 
t 60 174.6 ± 13.0 -23.6 175.3 ± 12.3 -25.1 175.7 ± 12.5 -26.8 
LDL-C 
(mg/dL) 
t 0 168.9 ± 13.0  181.1 ± 14.5  192.4 ± 13.8  
t 30 109.1 ± 12.7 -35.4 110.8 ± 12.0 -38.8 112.5 ± 14.4 -41.5 
t 60 108.3 ± 12.9 -35.9 111.7 ± 13.8 -38.3 112.0 ± 12.9 -41.8 
HDL-C 
(mg/dL) 
t 0 42.8 ± 3.7  39.1 ± 6.2  34.2 ± 5.3  
t 30 61.4 ± 4.4 +43.2 58.6 ± 5.2 +49.1 54.1 ± 4.8 +58.1 
t 60 62.1 ± 3.8 +45.3 59.0 ± 5.1 +50.7 53.3 ± 6.2 +56.2 
Glucose 
(mg/dL) 
t 0 107.2 ± 13.8  112.9 ± 13.6  113.4 ± 11.9  
t 30 106.2 ± 12.5 -0.9 111.2 ± 12.4 -1.2 112.2 ± 13.1 -1.5 
t 60 106.7 ± 14.6 -0.5 114.4 ± 10.9 +1.3 114.4 ± 10.3 +0.9 
Triglycerides 
(mg/dL) 
t 0 98.2 ± 10.5  91.1 ± 10.3  99.4 ± 10.3  
t 30 98.5 ± 11.2 +0.3 91.7 ± 12.8 +0.7 100.2 ± 13.0 +0.8 
t 60 99.5 ± 11.8 +1.3 91.2 ± 11.6 +0.1 99.6 ± 11.5 +0.2 
Subjects were administered with 2 AMS capsules/day for 2 months. 
Values are means ± SD (n = 5). 
Results were significantly different at a level of P = 0.001. 
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Table 12 Women TC: Effects of Annurca supplement (AMS) on plasma cholesterol, glucose and triglyceride metabolism in women 
subgroup according to total cholesterol (TC) at baseline. 
  Women 
(TC:214-229) 
Δ (%) 
Women 
(TC: 230-245) 
Δ (%) 
Women 
(TC: 246-254) 
Δ (%) 
TC 
(mg/dL) 
t 0 220.0 ± 11.7  232.0 ± 12.5  249.0 ± 12.1  
t 30 172.5 ± 13.5 -21.6 177.1 ± 13.1 -23.7 189.0 ± 13.5 -25.1 
t 60 172.0 ± 11.8 -21.8 177.7 ± 10.9 -23.4 188.2 ± 11.5 -25.4 
LDL-C 
(mg/dL) 
t 0 167.4 ± 13.4  182.3 ± 12.6  198.1 ± 12.7  
t 30 110.3 ± 12.5 -34.1 114.7 ± 14.2 -37.1 119.6 ± 11.2 -39.6 
t 60 109.0 ± 11.9 -34.9 115.0 ± 12.9 -36.9 120.6 ± 12.7 -39.1 
HDL-C 
(mg/dL) 
t 0 41.2 ± 4.5  37.9 ± 5.5  34.5 ± 4.3  
t 30 59.4 ± 5.2 +44.3 56.7 ± 4.6 +49.7 53.2 ± 5.7 +54.1 
t 60 60.0 ± 5.8 +44.8 56.5 ± 5.7 +49.1 53.1 ± 3.8 +54.2 
Glucose 
(mg/dL) 
t 0 114.5 ± 14.1  108.2 ± 12.7  102.7 ± 13.9  
t 30 113.9 ± 12.1 -0.5 107.8 ± 13.9 -0.4 101.3 ± 12.4 -1.4 
t 60 115.5 ± 10.4 +1.3 109.2 ± 11.8 +0.9 103.6 ± 14.8 0.9 
Triglycerides 
(mg/dL) 
t 0 95.2 ± 12.5  98.7 ± 13.9  88.7 ± 10.1  
t 30 96.0 ± 11.3 +0.8 98.1 ± 10.5 -0.6 89.3 ± 10.3 +0.7 
t 60 95.8 ± 14.7 +0.2 99.4 ± 13.8 +1.3 89.0 ± 10.2 +0.1 
Subjects were administered with 2 AMS capsules/day for 2 months. 
Values are means ± SD (n = 5). 
Results were significantly different at a level of P = 0.001. 
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Table 12 Women Age: Effects of Annurca supplement (AMS) on plasma cholesterol, glucose and triglyceride metabolism in women 
subgroup according to age. 
  
Women 
(Age: 30-45) 
Δ (%) 
Women 
(Age: 46-60) 
Δ (%) 
Women 
(Age: 61-83) 
Δ (%) 
TC 
(mg/dL) 
t 0 226.1 ± 13.6  234.5 ± 11.8  238.4 ± 13.2  
t 30 177.3 ± 10.8 -21.6 177.6 ± 12.5 -24.1 178.5 ± 12.1 -25.0 
t 60 176.6 ± 12.0 -21.9 177.3 ± 11.9 -24.4 178.0 ± 13.5 -25.2 
LDL-C 
(mg/dL) 
t 0 170.3 ± 11.5  182.6 ± 13.2  193.5 ± 12.1  
t 30 112.2 ± 13.1 -34.1 113.9 ± 14.1 -37.6 116.1 ± 13.8 -40.0 
t 60 111.9 ± 12.4 -34.3 113.5 ± 13.5 -37.8 114.9 ± 11.8 -40.6 
HDL-C 
(mg/dL) 
t 0 40.2 ± 3.2  38.2 ± 5.2  33.8 ± 4.3  
t 30 64.3 ± 5.9 +42.1 56.7 ± 6.4 +48.5 53.1 ± 5.7 +57.2 
t 60 56.9 ± 6.1 +41.5 57.5 ± 5.3 +50.6 51.9 ± 3.8 +53.6 
Glucose 
(mg/dL) 
t 0 111.4 ± 12.3  109.2 ± 13.3  105.2 ± 10.2  
t 30 112.2 ± 10.6 +1.0 107.8 ± 14.0 -1.3 104.3 ± 12.3 -0.8 
t 60 109.1 ± 10.1 -1.1 110.4 ± 10.0 +1.1 104.8 ± 13.1 -0.4 
Triglycerides 
(mg/dL) 
t 0 88.2 ± 11.1  93.3 ± 12.4  102.4 ± 12.5  
t 30 89.3 ± 12.7 +1.3 91.9 ± 10.7 +0.7 102.7 ± 13.0 +0.3 
t 60 88.4 ± 10.1 +0.2 94.3 ± 11.8 +1.1 103.2 ± 11.2 +0.8 
Subjects were administered with 2 AMS capsules/day for 2 months. 
Value are means ± SD (n = 5). 
Results were significantly different at a level of P = 0.001. 
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Good linear correlations between TC ranges and the entity of variation of plasma 
TC, LDL-C and HDL-C levels were registered (Table 12). The values of these 
correlations were: men with TC 214-229 mg/dL vs Δ TC, R = 0.95; men with TC 
230-245 mg/dL vs Δ HDL-C, R = 0.98; men with TC 246-254 mg/dL vs Δ LDL-
C, R = 0.96; women with TC 214-229 mg/dL vs Δ TC, R = 0.99; women with TC 
230-245 mg/dL vs Δ HDL-C, R = 0.95; women with TC 246-254 mg/dL vs Δ 
LDL-C, R = 0.96.  
Table 12 also highlights the existence of good linear correlations between age 
ranges and the entity of variation of plasma TC, LDL-C and HDL-C levels. The 
values of these correlations were: men aged 30-45 years old vs Δ TC, R = 0.98; 
men aged 46-60 years old vs Δ HDL-C, R = 0.98; men aged 61-83 years old vs Δ 
LDL-C, R = 0.96; women aged 30-45 years old vs Δ TC, R = 0.97; women aged 
46-60 years old vs Δ HDL-C, R = 0.94; women aged 61-83 years old vs Δ LDL-C, 
R = 0.98. Moreover, the entity of variation of plasma TC, LDL-C and HDL-C 
parameters is rather different according to the age subgroup. Specifically, the TC 
variation between the men 30-45 and 61-83 age subgroups is about -3%, the LDL-
C variation between the same groups is about -6%, whereas the change of HDL-C 
between the same groups is approximately +11%.  
On the basis of the obtained results, it can be asserted that two capsules of AMS 
exhibited a LDL-C lowering effect equivalent to 80 mg of fluvastatin, or 40 mg of 
simvastatin, or 10 mg of atorvastatin (Law et al., 2003), which belong to the 
pharmaceutical class of statins, the first-line lipid-lowering drug available on the 
market. Additionally, AMS may increase HDL-C levels by 49.2%, an effect far 
above to that obtained after administration of statins (+5-16%) and niacin (+30%). 
Finally, AMS is safer than statins, which have been related to several side effects, 
such as myopathy, type 2 diabetes onset and, recently, cancer risk incidence. The 
increase in cancer risk emerged in a trial that aimed to study the effect of the 
association simvastatin/ezetimibe (at 40 and 10 mg, respectively) in patients 
characterised by mild-to-moderate asymptomatic aortic stenosis. Specifically, it 
was observed a greater incidence of cancer in the group treated with 
simvastatin/ezetimibe (105 subjects) than in the group administered with placebo 
(70 subjects) (Rossebø et al., 2008). 
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Thus, to sum up the results obtained thanks to this clinical trial, AMS formulation: 
- strongly impacts on plasma HDL-C levels (+49.2%); 
- decreases LDL-C levels (-37.5%) and TC levels (-24.9%); 
- does not affect plasma glucose or triglyceride levels; 
- is more effective on elder people with higher values of baseline TC. 
The mechanism of action through which procyanidins exert lipid-lowering action 
has not been elucidated, but, on the basis of in vitro studies, it can be asserted that 
they may act in two different ways. Dimeric compounds (such as procyanidin B2) 
would have a statin-like mechanism (DeBose-Boyd et al., 2001; Bursill et al., 
2006; Yasuda et al., 2011), while polymeric compounds would not be absorbed by 
the intestine and may accumulate in the gut, where they may act with a β-
cyclodextrin-like mechanism (Leifert et al., 2008).  
 
6.2.5 Pharmacokinetics  
It is almost impossible to determine the pharmacokinetic profile of AMS in terms 
of absorption, distribution, metabolism and excretion because it does not contain a 
pure pharmaceutical substance, but it is constituted by a phytocomplex. Maybe, in 
order to obtain pharmacokinetic data, volunteers could be provided with AMS 
pure components (procyanidins, flavonols, dihydrochalcones and anthocyanins), 
but from literature data it is known that the pharmacokinetic profile within the 
same chemical group can be extremely variable (Manach et al., 2005). 
Nevertheless, data regarding the human pharmacokinetic profile of many 
constituents of AMS are already available from previous studies. In 2005 Manach 
and colleagues published a review that took into the account 97 studies, which 
investigated the kinetics and extent of polyphenolic compounds absorption in 
humans and showed that the flavanol epicatechin had mean values of Tmax (which 
is the time necessary to reach the Cmax) of 1.8 hours, the Cmax (which is the 
maximal plasma concentration) was at maximum 1.10 μmol/L and the half-life 
was of 2.5 hours. With regard to metabolism, several types of circulating 
metabolites were found: epicatechin-3‟-O-glucuronide, 4‟-O-methyl-epicatechin-
3‟-O-glucuronide, 4‟-O-methylepicatechin-5-O-glucuronide, 4‟-O-
methylepicatechin-7-O-glucuronide and the aglycones epicatechin and 4‟-O-
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methyl-epicatechin (Manach et al., 2005). As regards procyanidins, dimeric 
compounds were detected in human plasma 30 minutes after their consumption 
and reached the maximal plasma concentration of 41.4 nmol/L by 2 h (Holt et al., 
2002), whereas high molecular weight procyanidins were not absorbed by the 
intestine and could act locally (Ottaviani et al., 2012). 
 
6.2.6 Safety issue, study strength and limitations 
The safety of polyphenolic content of apples was assessed through mutagenicity 
tests and acute/subacute toxicity studies both in mice and humans, although no 
specific studies were conducted during this study. Particularly, the Commission 
Regulation (EC) No. 258/1997 established 1000 mg as the maximum 
polyphenolic extract daily intake in humans, because below this dose no 
significant hematological, clinical, chemical, histopathological or urinary effects 
were observed. For this trial, the dose adopted was of 800 mg/day, an amount 
close to but lower than that considered as safe in humans. All the laboratory 
analyses indicated that there were no alterations regarding the hepatic and renal 
function after two months of AMS treatment (Table 13). Moreover, patients were 
periodically monitored in order to assess vital signs, blood pressure and 
electrocardiographic findings and baseline values did not change substantially 
during and at the end of the trial (data not reported). 
The major strengths of this clinical trial reside in the originality of the study and 
in the evaluation of the treatment effects in real-world setting, while the main 
limitations of this study are short-term assessment for the treatment of a chronic 
condition and the choice of treating exclusively white race. 
 
 
 
 
112 
 
Table 13: Effects of Annurca supplement (AMS) on plasma indicators of hepatic and renal function in subgroups men and women. 
Men 
 AST (GOT) (U/L) ALT (GPT) (U/L) γ-GTP (U/L) ALP (U/L) 
 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 
Mean value 21.6 21.5 21.5 27.9 27.5 27.6 37.2 36.2 34.4 222.6 220.4 215.9 
Δ (%)  -0.46 -0.46  -1.43 -1.07  -2.68 -7.53  -0.99 -3.00 
 LDH (U/L) Albumin (g/dL) Total bilirubin (mg/dL) Creatinine (mg/dL) 
 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 
Mean value 177.0 176.5 170.2 4.31 4.32 4.16 0.57 0.57 0.54 0.84 0.82 0.80 
Δ (%)  -0.28 -3.84  +0.23 -3.48  - -5.26  -2.38 -4.76 
Women 
 AST (GOT) (U/L) ALT (GPT) (U/L) γ-GTP (U/L) ALP (U/L) 
 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 
Mean value 21.8 21.8 21.7 27.3 26.9 27.0 37.4 35.7 34.8 222.8 220.6 214.7 
Δ (%)  - -0.46  -1.46 -1.10  -4.54 -6.95  -0.99 -3.63 
 LDH (U/L) Albumin (g/dL) Total bilirubin (mg/dL) Creatinine (mg/dL) 
 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 
Mean value 179.9 178.8 172.2 4.41 4.32 4.23 0.59 0.57 0.54 0.83 0.80 0.79 
Δ (%)  -0.61 -4.28  -2.04 -4.08  -3.39 -8.47  -3.61 -4.82 
Subjects were administered with 2 AMS capsules/day for 2 months. 
Value are means ± SD (n = 5). 
Results were significantly different at a level of P = 0.001. 
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The positive results obtained suggest physicians a novel treatment/intervention, 
which may be a valuable alternative in the clinical practice. In fact, the Food and 
Drug Administration (FDA) has recently approved in the United States a 
nutraceutical product, constituted of Granny Smith apple polyphenolic extract and 
named Applephenon
®
, with the indication of reducing serum cholesterol levels 
and preventing obesity. A randomised human placebo-controlled intervention 
study with Applephenon
® 
at different dosages showed that the maximum dose 
(1500 mg/day) decreased plasma TC and LDL-C levels by 5% and 8%, 
respectively, and increased plasma HDL-C levels by 1% (Nagasako-Akazome et 
al., 2005). Instead, AppleMetS
TM
 was able to reduce TC and LDL-C levels by 
24.9% and 37.5%, respectively, and to raise HDL-C levels by 49.2%. These great 
discrepancies are due to the different polyphenolic composition (especially in the 
procyanidin fraction) of the different apple cultivars. 
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CONCLUSIONS 
The present thesis work aimed to the in vitro and in vivo evaluation of the 
nutraceutical potential of the polyphenolic fraction obtained from a specific apple 
cultivar, Annurca. Particularly, the effects of Annurca polyphenolic extract on 
lipid uptake and metabolism were evaluated and put in comparison with those 
obtained from other commercial cultivars. In in vitro studies the analyses were 
performed by using the following apple cultivars: Red Delicious, Pink Lady, Fuji 
and Golden Delicious; however, in in vivo experiments the cultivar Pink Lady was 
replaced by the cultivar Granny Smith, because of the reasons above-listed. 
In vitro experiments performed on HepG2 cells showed that, among peels, Red 
Delicious peel extract was the most active in reducing cholesterol and glucose 
uptake and in affecting lipid metabolism, since it reduced triglyceride uptake, 
inhibited lipase activity and increased LDL receptor binding activity and ApoA1 
expression. However, it revealed to be cytotoxic and able to induce oxidative 
stress, as shown by the decrease in cell proliferation, the increase in TBARS 
levels and the reduction in NO concentration. Thus, on the one hand these results 
confirmed that food supplements formulated with polyphenolic extracts obtained 
from this apple cultivar are effective, but on the other hand they address to the 
possible risks resulting from an incorrect use. Instead, the experiments conducted 
with Annurca flesh extract indicated that Annurca flesh polyphenols may be 
regarded as a good potential nutraceutical. In fact, they were able to decrease 
cholesterol uptake and to affect positively lipid metabolism also more than Red 
Delicious polyphenolic peel extract, but they did not show any kind of 
cytotoxicity.  
These amazing effects were attributed to procyanidins, which represent the most 
abundant polyphenols contained in apple flesh, and good linear correlations 
between procyanidin content and cellular effects were found.  
However, in order to achieve any effect in a specific tissue or organ, polyphenols 
must be available, so the successive step was the in vitro evaluation of some 
important parameters, such as bioaccessibility, bioavailability and plasma protein 
interaction. For this sort of analysis, in vitro experiments of gastrointestinal 
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digestion were performed, reproducing as closely as possible all the reactions that 
occur in human body. 
Polyphenols revealed to have a good bioaccessibility but a scarce bioavailability; 
moreover, the poor absorbed part was strongly bound to plasma proteins. 
Nevertheless their scarce absorption, procyanidins may accumulate in the gut, 
protecting the intestine from the attack of numerous oxidising agents and 
inhibiting dietary cholesterol uptake. Furthermore, bioavailable procyanidins 
interact significantly with plasma proteins, especially HDLs, suggesting they may 
play a role in the reverse transport and metabolism of cholesterol.  
In order to verify if the amazing in vitro properties of the polyphenolic fraction of 
Annurca apple were also maintained in vivo, two different clinical trials were 
performed.  
The first one aimed to evaluate in vivo effects on plasma TC, LDL-C, and HDL-C 
levels after the regular consumption of different apple cultivars (Annurca, Red 
Delicious, Granny Smith, Fuji and Golden Delicious), which were considered as 
functional foods. The data obtained after the first clinical trial showed that the 
effect of daily apple consumption on plasma cholesterol levels depends on the 
kind of apple cultivar and its polyphenolic composition. Particularly, the 
consumption of two Annurca apples per day had good effects for serum 
cholesterol levels in healthy subjects, as it decreased TC and LDL-C levels by 
8.4% and 14.5%, respectively, and increased HDL-C levels by 14.0%. This last 
effect seems to be the most important because very few natural or pharmaceutical 
substances have been reported to exert a positive influence on the so-called “good 
cholesterol”. Thus, these data indicate Annurca apple as a functional food for the 
maintenance of the healthy balance of plasma cholesterol levels, and it may be 
considered as a useful tool for the prevention of CVD risk through diet.  
The second in vivo study was based on the evaluation of the effects on plasma TC, 
LDL-C and HDL-C after the administration of the only polyphenolic fraction 
coming from Annurca apple cultivar. The administration of two capsules per day 
of AppleMetS
TM 
(AMS)
 
formulation (equivalent to the consumption of six 
Annurca apples per day) led to really excellent results on plasma values of TC, 
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LDL-C and HDL-C (-24.9%, -37.5% and +49.2%, respectively). Particularly, the 
effect on LDL-C is comparable to 10 mg of atorvastatin, which is the most potent 
statin available to date, whereas the important effect on HDL-C is not found in 
any pharmaceutical or nutraceutical substance. In particular, this nutraceutical 
product was more effective on elder people with higher values of baseline TC, 
who represent the major recipients of any hypolipidemic treatment.  
The first clinical trial demonstrates that a severe dietary intervention is necessary 
for cardiovascular disease prevention, but it is unrealistic to think that nutrition 
habits will change easily in industrialised countries. Instead, the second clinical 
trial leads to really excellent results and offers a simplified remedy with respect to 
diet transformation. Thus, the nutraceutical product may be considered as a 
complementary and/or alternative safe substance, suitable for the treatment of 
mildly hypercholesterolemic subjects who do not present occurrence of 
atheromatous plaques yet. 
The mechanism that underlies the cholesterol-lowering effects after the 
administration of whole fresh Annurca apple or AMS product would involve the 
action of procyanidins, which would act in different ways. Dimeric compounds 
(such as procyanidin B2) would have a statin-like LDL-lowering effect, by 
activating the SREBP-1 pathway and enhancing the expression of LDL receptor. 
Moreover, they would raise ApoA1 concentration and activate LCAT, exerting 
good effects also on plasma values of HDL. Polymeric compounds, instead, 
would not be absorbed by the intestine and may accumulate in the gut, where they 
may act with a β-cyclodextrin-like mechanism.  
To sum up, on the basis of the positive results obtained by in vitro experiments 
and in vivo clinical trials, Annurca polyphenols may represent a novel 
treatment/intervention thanks to their beneficial effects on cholesterol uptake and 
metabolism. 
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